[
  {
    "sentence": "These effects are harnessed for targeted tumor ablation, often with minimal damage to surrounding healthy tissues (Figure 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Different tumors have varying levels of infiltration into the skin tissue, ranging from superficial in squamous cell carcinoma to deeper in melanoma (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Phototherapy is primarily categorized into PDT, PTT, and PAT, or the combined treatment of PDT and PTT,9,10 each with distinct mechanisms (Figure 1C).11 In addition, other research teams have utilized vibronic-driven action to activate aminocyanines under near-infrared light, causing membrane disruption and subsequently inducing cell death.12 Local drug application minimizes toxic side effects on normal cells, while the light-stimulated response ensures precise, targeted treatment, reducing drug waste.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In contrast, laser ablation techniques that do not include PTT drugs have already begun to have already begun to see widely clinical applications.14\n\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The development of skin cancer is influenced by a combination of factors, but ultraviolet (UV) radiation from sunlight is the primary pathogenic factor for the occurrence and progression of skin cancer globally.16\nMelanoma and non-melanoma skin tumors account for more than one-third of all malignant tumors, making them the most common tumor types.16 Skin cancer is classified based on the cells of origin and clinical features and can be divided into NMSC and MSC.17 NMSC includes all non-melanoma malignant tumors affecting the skin.18 In epidemiological contexts, however, NMSC specifically refers to keratinocyte carcinoma, which includes BCC, SCC, and Cutaneous T-cell lymphoma (CTCL), as these account for 99% of this group of tumors (Figure 1B).19MSC\nMelanoma is considered a multifactorial disease and has the highest mutation rate among all cancers.20 Based on the common mutation patterns in melanoma, melanoma can be categorized into four subtypes. (i) BRAF-mutant (52% present), with BRAF mutations being the largest genomic subtype of melanoma.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "It was incubated with the oncolytic bacterium (Clostridium butyricum) to produce engineered oncolytic bacteria, which were then validated using a mouse model of malignant melanoma (Figure 2A).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Microscopic imaging and real-time monitoring results showed that the targeted Au@MTM-HA had the strongest ROS generation capability (Figure 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Compared to free Ce6, both PPC and PPC@HA enhanced the cellular uptake efficiency in B16 cells (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Thanks to HA-mediated targeted delivery and HA degradation-mediated charge reversal, the chemo-photodynamic combination therapy of PPC@HA+laser showed the most effective anti-tumor efficacy with the lowest tumor growth rate(Figure 2D and E).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel D",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Additionally, “hydrophobic and hydrophilic pockets” were constructed around the UCNPs, with hydrophobic PS (Ce6) and hydrophilic peroxidase (CTA) loaded into them (Figure 2G).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel G",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel G",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "After staining the cells with mitochondrial fluorescent dyes, it was observed that CTPP-modified NPs exhibited superior targeting and accumulation in the mitochondrial matrix compared to non-modified samples (Figure 2F).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel F",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel F",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Additionally, in vivo anticancer experiments revealed that tumors treated with the Ru4 + laser group significantly extended the survival time of mice (Figure 3C) and showed no significant dark toxicity (organ damage) (Figure 3E).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel E",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel E",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Although the absorption efficiency varied among different cell types, the PSs encapsulated within the cubic NPs showed enhanced cellular internalization and consequently stronger fluorescence signals (Figure 3A and B).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Surface markers on immune cells were stained 9 days after irradiation (Figure 3F).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel F",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel F",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "This leads to a higher level of infiltration of CD8 and CD4 T cells into tumors and lymph nodes (Figure 3G), which can kill tumor cells.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel G",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel G",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Ce6 generates ROS under light stimulation, which not only exerts PDT effects but also cleaves the disulfide bond to release CTX for chemotherapeutic action (Figure 3D).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel D",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel D",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "At the end of the treatment, tumor sections were stained with hematoxylin-eosin (H&E) for histological analysis, and the results showed that the synergistic treatment of psTKdC NAs and laser irradiation was effective in inducing apoptosis and necrosis of intratumor cells.(Figure 3H).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel H",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel H",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Additionally, terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling immunohistochemical staining confirmed the excellent combination of chemotherapy and photodynamic activity (Figure 3I).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel I",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel I",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The average inhibition rates for the NPs group, laser group, and NPs + laser group were 6%, 26%, and 57%, respectively (Figure 4A).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Melanin@RBC-M with a 1:1 weight ratio of red blood cell membrane to MCF-7 membrane proteins showed an increase in tumor temperature from 29.6°C to 54.0°C within 10 minutes (Figure 4D).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel D",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel D",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Compared to the weak tumor suppression ability of bare melanin NPs, the 1:1 group of Melanin@RBC-M demonstrated complete tumor elimination (Figure 4E and F).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel E",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The researchers conducted an in vitro evaluation of transdermal performance (Figure 4B).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The penetration efficiency of (+)T-SiDs was significantly higher than that of (+)SiDs (without TD), and the fluorescence intensity of the skin sections was also markedly stronger than the latter (Figure 4C), demonstrating higher transdermal permeability.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel C",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel C",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "However, the temperatures of the transdermally treated group increased gradually to 46°C, which was higher than that of the injected group at 43°C, and the temperatures of the injected group were higher than that of the injected group. (Figure 4D and E).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel D",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Twenty-four hours after treatment, tumor sections stained for analysis showed varying degrees of cell lysis and disruption, leading to significant necrosis and apoptosis of tumor cells (Figure 4F).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel F",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel F",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Ho et al155 developed a nanographene oxide-hyaluronic acid conjugate (NGO-HA) for photothermal ablation therapy of MSC (Figure 5A).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "When the concentration of NGO-HA exceeds 250 μg/mL, NIR irradiation for 10 minutes can raise the temperature of the NGO-HA solution by approximately 40°C (Figure 5B), sufficient to induce a photothermal effect.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Due to the transdermal properties of HA derivatives, NGO-HA can significantly penetrate the compromised cancerous skin barrier (Figure 5C).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel C",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel C",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "However, wound healing and skin regeneration following traditional skin tumor surgery and chronic bacterial infection-induced wounds remain a challenge.157 The formation of chronic wounds is closely related to the presence of pathogenic bacteria in the postoperative skin defect.158 Timely application of antibiotics can reduce bacterial infection; however, the emergence of multidrug-resistant (MDR) bacteria increases the risk of chronic wounds.159 Wang et al156 developed a novel double-crosslinked BMH hydrogel (Figure 5D), which is injectable, adhesive, redox/photo-responsive, and has inherent antibacterial properties.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel D",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel D",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Furthermore, its antibacterial effect lasted longer, demonstrating a 100% antibacterial rate 14 days post-treatment (Figure 5E).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Additionally, the wound defects in the BMH hydrogel group almost disappeared by day 14 (Figure 5F).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel F",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel F",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "After PBVac + Light treatment, compared to the control group, the appearance of radiation dermatitis and scarring was alleviated, and hair growth was restored (Figure 5G).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel G",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel G",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Histological analysis revealed better epithelial continuity in the PBVac + Light group (Figure 5H) and increased skin appendages, including hair follicles and blood vessels, along with enhanced collagen accumulation by day 28.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel H",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel H",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "In terms of antitumor activity, PBVac showed a minimal 1.5-fold increase in tumor volume compared to a 40-fold increase in the PBS and PB nanozyme groups (Figure 5I).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel I",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel I",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Post-PTT, most cancer cells exhibited shrinkage and necrosis (Figure 6A).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Under the influence of CD47 receptor-mediated targeting by nGO-COS, the nanocomposite material achieved a high uptake intensity in melanoma cells at a relatively low concentration (5 μg/mL) (Figure 6C).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "This indicates a high photothermal conversion efficiency, which is proportional to concentration and laser power intensity, making it suitable for use as a thermotherapeutic agent (Figure 6H).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel H",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel H",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "At the same drug concentration, the number of cancer cells killed after treatment with free DTIC was significantly lower compared to nGO-COS-CD47/DTIC (Figure 6D).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The researchers constructed the nanoplatforms HA-PAMAM-COOH-TMZ and HA-PAMAM-COOH-ICG by loading temozolomide and indocyanine green onto HA-modified carboxylated polyamidoamine, respectively, for combined chemotherapy and PTT/PDT (Figure 6B).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Under near-infrared light irradiation, as the concentration of ICG increased, the temperature of HPCI rose, reaching over 50°C at its peak (Figure 6E).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel E",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel E",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Moreover, at the same concentration, the heating capacity of HPCI was similar to that of free ICG (Figure 6F), while the production of ROS was higher than that of free ICG (Figure 6G), indicating that HPCI has a good foundational capability for synergistic PTT/PDT treatment.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel F",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel G",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel F",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel G",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In the PAI validation experiments, untreated control cells showed the lowest PA amplitude, while cells incubated with MnO2 nanotubes exhibited the highest PA amplitude, which was 2.2 times higher than the control group and showed the slowest decrease in amplitude (Figure 7G).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel G",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel G",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "In PAI, the stability of nanomaterials is a non-negligible issue, in order to study the stability of MnO2 nanotubes in repetitive imaging, the researchers detected the PA signals of 2 mg/mL manganese dioxide nanotubes at 100, 2000, 4000, 8000 and 16000 laser pulses, respectively, and the results showed that there was no significant difference in the PA signals obtained at different laser pulses, and the this also proves the good stability of MnO2 nanotubes in PAI. (Figure 7A).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The experiments also ruled out the dilution effect caused by tumor growth as a factor for the reduction in PA signal, confirming the sensitivity of MnO2 nanotubes as PA probes for PAI (Figure 7B and C).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel B",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The researchers also conducted in vivo experiments and found that AuNRs could specifically accumulate at tumor sites, acting as contrast agents in PAI(Figure 7E).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel E",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel E",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Continued.Figure 8.\n\n(A) Histological staining of organs in mice 25 days after treatment.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "When PBP and BP contrast agents were separately injected intravenously into tumor-bearing mice, the mice injected with PBP exhibited higher contrast in the tumor region on PAI, with a duration of up to 24 hours (Figure 8B).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel B",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel B",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The maximum cell apoptosis rate reached 74% (Figure 8C and D).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel C",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "A noticeable infiltration of CD8+ cells in the tumor site was observed (Figure 8E–G).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel E",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Phototherapy applied to skin cancer can function through PDT, PTT, and PA (Figure 1), offering both diagnostic and therapeutic effects.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Additionally, improving platform structural compatibility to achieve multifunctional effects simultaneously, enhancing therapeutic outcomes, and increasing indications is also a viable strategy (Figure 4G).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel G",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel G",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "These effects are harnessed for targeted tumor ablation, often with minimal damage to surrounding healthy tissues (Figure 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Different tumors have varying levels of infiltration into the skin tissue, ranging from superficial in squamous cell carcinoma to deeper in melanoma (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Phototherapy is primarily categorized into PDT, PTT, and PAT, or the combined treatment of PDT and PTT,9,10 each with distinct mechanisms (Figure 1C).11 In addition, other research teams have utilized vibronic-driven action to activate aminocyanines under near-infrared light, causing membrane disruption and subsequently inducing cell death.12 Local drug application minimizes toxic side effects on normal cells, while the light-stimulated response ensures precise, targeted treatment, reducing drug waste.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In contrast, laser ablation techniques that do not include PTT drugs have already begun to have already begun to see widely clinical applications.14\n\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The development of skin cancer is influenced by a combination of factors, but ultraviolet (UV) radiation from sunlight is the primary pathogenic factor for the occurrence and progression of skin cancer globally.16\nMelanoma and non-melanoma skin tumors account for more than one-third of all malignant tumors, making them the most common tumor types.16 Skin cancer is classified based on the cells of origin and clinical features and can be divided into NMSC and MSC.17 NMSC includes all non-melanoma malignant tumors affecting the skin.18 In epidemiological contexts, however, NMSC specifically refers to keratinocyte carcinoma, which includes BCC, SCC, and Cutaneous T-cell lymphoma (CTCL), as these account for 99% of this group of tumors (Figure 1B).19MSC\nMelanoma is considered a multifactorial disease and has the highest mutation rate among all cancers.20 Based on the common mutation patterns in melanoma, melanoma can be categorized into four subtypes. (i) BRAF-mutant (52% present), with BRAF mutations being the largest genomic subtype of melanoma.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "It was incubated with the oncolytic bacterium (Clostridium butyricum) to produce engineered oncolytic bacteria, which were then validated using a mouse model of malignant melanoma (Figure 2A).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Microscopic imaging and real-time monitoring results showed that the targeted Au@MTM-HA had the strongest ROS generation capability (Figure 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Compared to free Ce6, both PPC and PPC@HA enhanced the cellular uptake efficiency in B16 cells (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Thanks to HA-mediated targeted delivery and HA degradation-mediated charge reversal, the chemo-photodynamic combination therapy of PPC@HA+laser showed the most effective anti-tumor efficacy with the lowest tumor growth rate(Figure 2D and E).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel D",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Additionally, “hydrophobic and hydrophilic pockets” were constructed around the UCNPs, with hydrophobic PS (Ce6) and hydrophilic peroxidase (CTA) loaded into them (Figure 2G).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel G",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel G",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "After staining the cells with mitochondrial fluorescent dyes, it was observed that CTPP-modified NPs exhibited superior targeting and accumulation in the mitochondrial matrix compared to non-modified samples (Figure 2F).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel F",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel F",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Additionally, in vivo anticancer experiments revealed that tumors treated with the Ru4 + laser group significantly extended the survival time of mice (Figure 3C) and showed no significant dark toxicity (organ damage) (Figure 3E).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel E",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel E",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Although the absorption efficiency varied among different cell types, the PSs encapsulated within the cubic NPs showed enhanced cellular internalization and consequently stronger fluorescence signals (Figure 3A and B).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Surface markers on immune cells were stained 9 days after irradiation (Figure 3F).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel F",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel F",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "This leads to a higher level of infiltration of CD8 and CD4 T cells into tumors and lymph nodes (Figure 3G), which can kill tumor cells.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel G",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel G",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Ce6 generates ROS under light stimulation, which not only exerts PDT effects but also cleaves the disulfide bond to release CTX for chemotherapeutic action (Figure 3D).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel D",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel D",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "At the end of the treatment, tumor sections were stained with hematoxylin-eosin (H&E) for histological analysis, and the results showed that the synergistic treatment of psTKdC NAs and laser irradiation was effective in inducing apoptosis and necrosis of intratumor cells.(Figure 3H).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel H",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel H",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Additionally, terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling immunohistochemical staining confirmed the excellent combination of chemotherapy and photodynamic activity (Figure 3I).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel I",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel I",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The average inhibition rates for the NPs group, laser group, and NPs + laser group were 6%, 26%, and 57%, respectively (Figure 4A).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Melanin@RBC-M with a 1:1 weight ratio of red blood cell membrane to MCF-7 membrane proteins showed an increase in tumor temperature from 29.6°C to 54.0°C within 10 minutes (Figure 4D).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel D",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel D",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Compared to the weak tumor suppression ability of bare melanin NPs, the 1:1 group of Melanin@RBC-M demonstrated complete tumor elimination (Figure 4E and F).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel E",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The researchers conducted an in vitro evaluation of transdermal performance (Figure 4B).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The penetration efficiency of (+)T-SiDs was significantly higher than that of (+)SiDs (without TD), and the fluorescence intensity of the skin sections was also markedly stronger than the latter (Figure 4C), demonstrating higher transdermal permeability.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel C",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel C",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "However, the temperatures of the transdermally treated group increased gradually to 46°C, which was higher than that of the injected group at 43°C, and the temperatures of the injected group were higher than that of the injected group. (Figure 4D and E).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel D",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Twenty-four hours after treatment, tumor sections stained for analysis showed varying degrees of cell lysis and disruption, leading to significant necrosis and apoptosis of tumor cells (Figure 4F).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel F",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel F",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Ho et al155 developed a nanographene oxide-hyaluronic acid conjugate (NGO-HA) for photothermal ablation therapy of MSC (Figure 5A).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "When the concentration of NGO-HA exceeds 250 μg/mL, NIR irradiation for 10 minutes can raise the temperature of the NGO-HA solution by approximately 40°C (Figure 5B), sufficient to induce a photothermal effect.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Due to the transdermal properties of HA derivatives, NGO-HA can significantly penetrate the compromised cancerous skin barrier (Figure 5C).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel C",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel C",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "However, wound healing and skin regeneration following traditional skin tumor surgery and chronic bacterial infection-induced wounds remain a challenge.157 The formation of chronic wounds is closely related to the presence of pathogenic bacteria in the postoperative skin defect.158 Timely application of antibiotics can reduce bacterial infection; however, the emergence of multidrug-resistant (MDR) bacteria increases the risk of chronic wounds.159 Wang et al156 developed a novel double-crosslinked BMH hydrogel (Figure 5D), which is injectable, adhesive, redox/photo-responsive, and has inherent antibacterial properties.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel D",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel D",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Furthermore, its antibacterial effect lasted longer, demonstrating a 100% antibacterial rate 14 days post-treatment (Figure 5E).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Additionally, the wound defects in the BMH hydrogel group almost disappeared by day 14 (Figure 5F).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel F",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel F",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "After PBVac + Light treatment, compared to the control group, the appearance of radiation dermatitis and scarring was alleviated, and hair growth was restored (Figure 5G).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel G",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel G",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Histological analysis revealed better epithelial continuity in the PBVac + Light group (Figure 5H) and increased skin appendages, including hair follicles and blood vessels, along with enhanced collagen accumulation by day 28.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel H",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel H",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "In terms of antitumor activity, PBVac showed a minimal 1.5-fold increase in tumor volume compared to a 40-fold increase in the PBS and PB nanozyme groups (Figure 5I).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel I",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel I",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Post-PTT, most cancer cells exhibited shrinkage and necrosis (Figure 6A).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Under the influence of CD47 receptor-mediated targeting by nGO-COS, the nanocomposite material achieved a high uptake intensity in melanoma cells at a relatively low concentration (5 μg/mL) (Figure 6C).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "This indicates a high photothermal conversion efficiency, which is proportional to concentration and laser power intensity, making it suitable for use as a thermotherapeutic agent (Figure 6H).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel H",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel H",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "At the same drug concentration, the number of cancer cells killed after treatment with free DTIC was significantly lower compared to nGO-COS-CD47/DTIC (Figure 6D).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The researchers constructed the nanoplatforms HA-PAMAM-COOH-TMZ and HA-PAMAM-COOH-ICG by loading temozolomide and indocyanine green onto HA-modified carboxylated polyamidoamine, respectively, for combined chemotherapy and PTT/PDT (Figure 6B).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Under near-infrared light irradiation, as the concentration of ICG increased, the temperature of HPCI rose, reaching over 50°C at its peak (Figure 6E).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel E",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel E",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Moreover, at the same concentration, the heating capacity of HPCI was similar to that of free ICG (Figure 6F), while the production of ROS was higher than that of free ICG (Figure 6G), indicating that HPCI has a good foundational capability for synergistic PTT/PDT treatment.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel F",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel G",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel F",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel G",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In the PAI validation experiments, untreated control cells showed the lowest PA amplitude, while cells incubated with MnO2 nanotubes exhibited the highest PA amplitude, which was 2.2 times higher than the control group and showed the slowest decrease in amplitude (Figure 7G).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel G",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel G",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "In PAI, the stability of nanomaterials is a non-negligible issue, in order to study the stability of MnO2 nanotubes in repetitive imaging, the researchers detected the PA signals of 2 mg/mL manganese dioxide nanotubes at 100, 2000, 4000, 8000 and 16000 laser pulses, respectively, and the results showed that there was no significant difference in the PA signals obtained at different laser pulses, and the this also proves the good stability of MnO2 nanotubes in PAI. (Figure 7A).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The experiments also ruled out the dilution effect caused by tumor growth as a factor for the reduction in PA signal, confirming the sensitivity of MnO2 nanotubes as PA probes for PAI (Figure 7B and C).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel B",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The researchers also conducted in vivo experiments and found that AuNRs could specifically accumulate at tumor sites, acting as contrast agents in PAI(Figure 7E).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel E",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel E",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Continued.Figure 8.\n\n(A) Histological staining of organs in mice 25 days after treatment.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "When PBP and BP contrast agents were separately injected intravenously into tumor-bearing mice, the mice injected with PBP exhibited higher contrast in the tumor region on PAI, with a duration of up to 24 hours (Figure 8B).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel B",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel B",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The maximum cell apoptosis rate reached 74% (Figure 8C and D).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel C",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "A noticeable infiltration of CD8+ cells in the tumor site was observed (Figure 8E–G).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel E",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Phototherapy applied to skin cancer can function through PDT, PTT, and PA (Figure 1), offering both diagnostic and therapeutic effects.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Additionally, improving platform structural compatibility to achieve multifunctional effects simultaneously, enhancing therapeutic outcomes, and increasing indications is also a viable strategy (Figure 4G).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel G",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel G",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "These effects are harnessed for targeted tumor ablation, often with minimal damage to surrounding healthy tissues (Figure 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Different tumors have varying levels of infiltration into the skin tissue, ranging from superficial in squamous cell carcinoma to deeper in melanoma (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Phototherapy is primarily categorized into PDT, PTT, and PAT, or the combined treatment of PDT and PTT,9,10 each with distinct mechanisms (Figure 1C).11 In addition, other research teams have utilized vibronic-driven action to activate aminocyanines under near-infrared light, causing membrane disruption and subsequently inducing cell death.12 Local drug application minimizes toxic side effects on normal cells, while the light-stimulated response ensures precise, targeted treatment, reducing drug waste.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In contrast, laser ablation techniques that do not include PTT drugs have already begun to have already begun to see widely clinical applications.14\n\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The development of skin cancer is influenced by a combination of factors, but ultraviolet (UV) radiation from sunlight is the primary pathogenic factor for the occurrence and progression of skin cancer globally.16\nMelanoma and non-melanoma skin tumors account for more than one-third of all malignant tumors, making them the most common tumor types.16 Skin cancer is classified based on the cells of origin and clinical features and can be divided into NMSC and MSC.17 NMSC includes all non-melanoma malignant tumors affecting the skin.18 In epidemiological contexts, however, NMSC specifically refers to keratinocyte carcinoma, which includes BCC, SCC, and Cutaneous T-cell lymphoma (CTCL), as these account for 99% of this group of tumors (Figure 1B).19MSC\nMelanoma is considered a multifactorial disease and has the highest mutation rate among all cancers.20 Based on the common mutation patterns in melanoma, melanoma can be categorized into four subtypes. (i) BRAF-mutant (52% present), with BRAF mutations being the largest genomic subtype of melanoma.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "It was incubated with the oncolytic bacterium (Clostridium butyricum) to produce engineered oncolytic bacteria, which were then validated using a mouse model of malignant melanoma (Figure 2A).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Microscopic imaging and real-time monitoring results showed that the targeted Au@MTM-HA had the strongest ROS generation capability (Figure 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Compared to free Ce6, both PPC and PPC@HA enhanced the cellular uptake efficiency in B16 cells (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Thanks to HA-mediated targeted delivery and HA degradation-mediated charge reversal, the chemo-photodynamic combination therapy of PPC@HA+laser showed the most effective anti-tumor efficacy with the lowest tumor growth rate(Figure 2D and E).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel D",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Additionally, “hydrophobic and hydrophilic pockets” were constructed around the UCNPs, with hydrophobic PS (Ce6) and hydrophilic peroxidase (CTA) loaded into them (Figure 2G).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel G",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel G",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "After staining the cells with mitochondrial fluorescent dyes, it was observed that CTPP-modified NPs exhibited superior targeting and accumulation in the mitochondrial matrix compared to non-modified samples (Figure 2F).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel F",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel F",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Additionally, in vivo anticancer experiments revealed that tumors treated with the Ru4 + laser group significantly extended the survival time of mice (Figure 3C) and showed no significant dark toxicity (organ damage) (Figure 3E).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel E",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel E",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Although the absorption efficiency varied among different cell types, the PSs encapsulated within the cubic NPs showed enhanced cellular internalization and consequently stronger fluorescence signals (Figure 3A and B).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Surface markers on immune cells were stained 9 days after irradiation (Figure 3F).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel F",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel F",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "This leads to a higher level of infiltration of CD8 and CD4 T cells into tumors and lymph nodes (Figure 3G), which can kill tumor cells.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel G",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel G",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Ce6 generates ROS under light stimulation, which not only exerts PDT effects but also cleaves the disulfide bond to release CTX for chemotherapeutic action (Figure 3D).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel D",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel D",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "At the end of the treatment, tumor sections were stained with hematoxylin-eosin (H&E) for histological analysis, and the results showed that the synergistic treatment of psTKdC NAs and laser irradiation was effective in inducing apoptosis and necrosis of intratumor cells.(Figure 3H).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel H",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel H",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Additionally, terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling immunohistochemical staining confirmed the excellent combination of chemotherapy and photodynamic activity (Figure 3I).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel I",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel I",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The average inhibition rates for the NPs group, laser group, and NPs + laser group were 6%, 26%, and 57%, respectively (Figure 4A).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Melanin@RBC-M with a 1:1 weight ratio of red blood cell membrane to MCF-7 membrane proteins showed an increase in tumor temperature from 29.6°C to 54.0°C within 10 minutes (Figure 4D).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel D",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel D",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Compared to the weak tumor suppression ability of bare melanin NPs, the 1:1 group of Melanin@RBC-M demonstrated complete tumor elimination (Figure 4E and F).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel E",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The researchers conducted an in vitro evaluation of transdermal performance (Figure 4B).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The penetration efficiency of (+)T-SiDs was significantly higher than that of (+)SiDs (without TD), and the fluorescence intensity of the skin sections was also markedly stronger than the latter (Figure 4C), demonstrating higher transdermal permeability.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel C",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel C",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "However, the temperatures of the transdermally treated group increased gradually to 46°C, which was higher than that of the injected group at 43°C, and the temperatures of the injected group were higher than that of the injected group. (Figure 4D and E).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel D",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Twenty-four hours after treatment, tumor sections stained for analysis showed varying degrees of cell lysis and disruption, leading to significant necrosis and apoptosis of tumor cells (Figure 4F).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel F",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel F",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Ho et al155 developed a nanographene oxide-hyaluronic acid conjugate (NGO-HA) for photothermal ablation therapy of MSC (Figure 5A).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "When the concentration of NGO-HA exceeds 250 μg/mL, NIR irradiation for 10 minutes can raise the temperature of the NGO-HA solution by approximately 40°C (Figure 5B), sufficient to induce a photothermal effect.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Due to the transdermal properties of HA derivatives, NGO-HA can significantly penetrate the compromised cancerous skin barrier (Figure 5C).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel C",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel C",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "However, wound healing and skin regeneration following traditional skin tumor surgery and chronic bacterial infection-induced wounds remain a challenge.157 The formation of chronic wounds is closely related to the presence of pathogenic bacteria in the postoperative skin defect.158 Timely application of antibiotics can reduce bacterial infection; however, the emergence of multidrug-resistant (MDR) bacteria increases the risk of chronic wounds.159 Wang et al156 developed a novel double-crosslinked BMH hydrogel (Figure 5D), which is injectable, adhesive, redox/photo-responsive, and has inherent antibacterial properties.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel D",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel D",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Furthermore, its antibacterial effect lasted longer, demonstrating a 100% antibacterial rate 14 days post-treatment (Figure 5E).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Additionally, the wound defects in the BMH hydrogel group almost disappeared by day 14 (Figure 5F).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel F",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel F",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "After PBVac + Light treatment, compared to the control group, the appearance of radiation dermatitis and scarring was alleviated, and hair growth was restored (Figure 5G).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel G",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel G",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Histological analysis revealed better epithelial continuity in the PBVac + Light group (Figure 5H) and increased skin appendages, including hair follicles and blood vessels, along with enhanced collagen accumulation by day 28.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel H",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel H",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "In terms of antitumor activity, PBVac showed a minimal 1.5-fold increase in tumor volume compared to a 40-fold increase in the PBS and PB nanozyme groups (Figure 5I).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel I",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel I",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Post-PTT, most cancer cells exhibited shrinkage and necrosis (Figure 6A).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Under the influence of CD47 receptor-mediated targeting by nGO-COS, the nanocomposite material achieved a high uptake intensity in melanoma cells at a relatively low concentration (5 μg/mL) (Figure 6C).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "This indicates a high photothermal conversion efficiency, which is proportional to concentration and laser power intensity, making it suitable for use as a thermotherapeutic agent (Figure 6H).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel H",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel H",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "At the same drug concentration, the number of cancer cells killed after treatment with free DTIC was significantly lower compared to nGO-COS-CD47/DTIC (Figure 6D).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The researchers constructed the nanoplatforms HA-PAMAM-COOH-TMZ and HA-PAMAM-COOH-ICG by loading temozolomide and indocyanine green onto HA-modified carboxylated polyamidoamine, respectively, for combined chemotherapy and PTT/PDT (Figure 6B).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Under near-infrared light irradiation, as the concentration of ICG increased, the temperature of HPCI rose, reaching over 50°C at its peak (Figure 6E).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel E",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel E",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Moreover, at the same concentration, the heating capacity of HPCI was similar to that of free ICG (Figure 6F), while the production of ROS was higher than that of free ICG (Figure 6G), indicating that HPCI has a good foundational capability for synergistic PTT/PDT treatment.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel F",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel G",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel F",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel G",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In the PAI validation experiments, untreated control cells showed the lowest PA amplitude, while cells incubated with MnO2 nanotubes exhibited the highest PA amplitude, which was 2.2 times higher than the control group and showed the slowest decrease in amplitude (Figure 7G).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel G",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel G",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "In PAI, the stability of nanomaterials is a non-negligible issue, in order to study the stability of MnO2 nanotubes in repetitive imaging, the researchers detected the PA signals of 2 mg/mL manganese dioxide nanotubes at 100, 2000, 4000, 8000 and 16000 laser pulses, respectively, and the results showed that there was no significant difference in the PA signals obtained at different laser pulses, and the this also proves the good stability of MnO2 nanotubes in PAI. (Figure 7A).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The experiments also ruled out the dilution effect caused by tumor growth as a factor for the reduction in PA signal, confirming the sensitivity of MnO2 nanotubes as PA probes for PAI (Figure 7B and C).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel B",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The researchers also conducted in vivo experiments and found that AuNRs could specifically accumulate at tumor sites, acting as contrast agents in PAI(Figure 7E).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel E",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel E",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Continued.Figure 8.\n\n(A) Histological staining of organs in mice 25 days after treatment.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "When PBP and BP contrast agents were separately injected intravenously into tumor-bearing mice, the mice injected with PBP exhibited higher contrast in the tumor region on PAI, with a duration of up to 24 hours (Figure 8B).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel B",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel B",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The maximum cell apoptosis rate reached 74% (Figure 8C and D).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel C",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "A noticeable infiltration of CD8+ cells in the tumor site was observed (Figure 8E–G).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel E",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Phototherapy applied to skin cancer can function through PDT, PTT, and PA (Figure 1), offering both diagnostic and therapeutic effects.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Additionally, improving platform structural compatibility to achieve multifunctional effects simultaneously, enhancing therapeutic outcomes, and increasing indications is also a viable strategy (Figure 4G).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel G",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel G",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "These effects are harnessed for targeted tumor ablation, often with minimal damage to surrounding healthy tissues (Figure 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Different tumors have varying levels of infiltration into the skin tissue, ranging from superficial in squamous cell carcinoma to deeper in melanoma (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Phototherapy is primarily categorized into PDT, PTT, and PAT, or the combined treatment of PDT and PTT,9,10 each with distinct mechanisms (Figure 1C).11 In addition, other research teams have utilized vibronic-driven action to activate aminocyanines under near-infrared light, causing membrane disruption and subsequently inducing cell death.12 Local drug application minimizes toxic side effects on normal cells, while the light-stimulated response ensures precise, targeted treatment, reducing drug waste.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In contrast, laser ablation techniques that do not include PTT drugs have already begun to have already begun to see widely clinical applications.14\n\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The development of skin cancer is influenced by a combination of factors, but ultraviolet (UV) radiation from sunlight is the primary pathogenic factor for the occurrence and progression of skin cancer globally.16\nMelanoma and non-melanoma skin tumors account for more than one-third of all malignant tumors, making them the most common tumor types.16 Skin cancer is classified based on the cells of origin and clinical features and can be divided into NMSC and MSC.17 NMSC includes all non-melanoma malignant tumors affecting the skin.18 In epidemiological contexts, however, NMSC specifically refers to keratinocyte carcinoma, which includes BCC, SCC, and Cutaneous T-cell lymphoma (CTCL), as these account for 99% of this group of tumors (Figure 1B).19MSC\nMelanoma is considered a multifactorial disease and has the highest mutation rate among all cancers.20 Based on the common mutation patterns in melanoma, melanoma can be categorized into four subtypes. (i) BRAF-mutant (52% present), with BRAF mutations being the largest genomic subtype of melanoma.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "It was incubated with the oncolytic bacterium (Clostridium butyricum) to produce engineered oncolytic bacteria, which were then validated using a mouse model of malignant melanoma (Figure 2A).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Microscopic imaging and real-time monitoring results showed that the targeted Au@MTM-HA had the strongest ROS generation capability (Figure 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Compared to free Ce6, both PPC and PPC@HA enhanced the cellular uptake efficiency in B16 cells (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Thanks to HA-mediated targeted delivery and HA degradation-mediated charge reversal, the chemo-photodynamic combination therapy of PPC@HA+laser showed the most effective anti-tumor efficacy with the lowest tumor growth rate(Figure 2D and E).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel D",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Additionally, “hydrophobic and hydrophilic pockets” were constructed around the UCNPs, with hydrophobic PS (Ce6) and hydrophilic peroxidase (CTA) loaded into them (Figure 2G).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel G",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel G",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "After staining the cells with mitochondrial fluorescent dyes, it was observed that CTPP-modified NPs exhibited superior targeting and accumulation in the mitochondrial matrix compared to non-modified samples (Figure 2F).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel F",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel F",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Additionally, in vivo anticancer experiments revealed that tumors treated with the Ru4 + laser group significantly extended the survival time of mice (Figure 3C) and showed no significant dark toxicity (organ damage) (Figure 3E).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel E",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel E",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Although the absorption efficiency varied among different cell types, the PSs encapsulated within the cubic NPs showed enhanced cellular internalization and consequently stronger fluorescence signals (Figure 3A and B).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Surface markers on immune cells were stained 9 days after irradiation (Figure 3F).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel F",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel F",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "This leads to a higher level of infiltration of CD8 and CD4 T cells into tumors and lymph nodes (Figure 3G), which can kill tumor cells.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel G",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel G",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Ce6 generates ROS under light stimulation, which not only exerts PDT effects but also cleaves the disulfide bond to release CTX for chemotherapeutic action (Figure 3D).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel D",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel D",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "At the end of the treatment, tumor sections were stained with hematoxylin-eosin (H&E) for histological analysis, and the results showed that the synergistic treatment of psTKdC NAs and laser irradiation was effective in inducing apoptosis and necrosis of intratumor cells.(Figure 3H).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel H",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel H",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Additionally, terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling immunohistochemical staining confirmed the excellent combination of chemotherapy and photodynamic activity (Figure 3I).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel I",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel I",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The average inhibition rates for the NPs group, laser group, and NPs + laser group were 6%, 26%, and 57%, respectively (Figure 4A).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Melanin@RBC-M with a 1:1 weight ratio of red blood cell membrane to MCF-7 membrane proteins showed an increase in tumor temperature from 29.6°C to 54.0°C within 10 minutes (Figure 4D).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel D",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel D",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Compared to the weak tumor suppression ability of bare melanin NPs, the 1:1 group of Melanin@RBC-M demonstrated complete tumor elimination (Figure 4E and F).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel E",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The researchers conducted an in vitro evaluation of transdermal performance (Figure 4B).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The penetration efficiency of (+)T-SiDs was significantly higher than that of (+)SiDs (without TD), and the fluorescence intensity of the skin sections was also markedly stronger than the latter (Figure 4C), demonstrating higher transdermal permeability.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel C",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel C",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "However, the temperatures of the transdermally treated group increased gradually to 46°C, which was higher than that of the injected group at 43°C, and the temperatures of the injected group were higher than that of the injected group. (Figure 4D and E).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel D",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Twenty-four hours after treatment, tumor sections stained for analysis showed varying degrees of cell lysis and disruption, leading to significant necrosis and apoptosis of tumor cells (Figure 4F).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel F",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel F",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Ho et al155 developed a nanographene oxide-hyaluronic acid conjugate (NGO-HA) for photothermal ablation therapy of MSC (Figure 5A).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "When the concentration of NGO-HA exceeds 250 μg/mL, NIR irradiation for 10 minutes can raise the temperature of the NGO-HA solution by approximately 40°C (Figure 5B), sufficient to induce a photothermal effect.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Due to the transdermal properties of HA derivatives, NGO-HA can significantly penetrate the compromised cancerous skin barrier (Figure 5C).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel C",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel C",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "However, wound healing and skin regeneration following traditional skin tumor surgery and chronic bacterial infection-induced wounds remain a challenge.157 The formation of chronic wounds is closely related to the presence of pathogenic bacteria in the postoperative skin defect.158 Timely application of antibiotics can reduce bacterial infection; however, the emergence of multidrug-resistant (MDR) bacteria increases the risk of chronic wounds.159 Wang et al156 developed a novel double-crosslinked BMH hydrogel (Figure 5D), which is injectable, adhesive, redox/photo-responsive, and has inherent antibacterial properties.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel D",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel D",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Furthermore, its antibacterial effect lasted longer, demonstrating a 100% antibacterial rate 14 days post-treatment (Figure 5E).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Additionally, the wound defects in the BMH hydrogel group almost disappeared by day 14 (Figure 5F).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel F",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel F",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "After PBVac + Light treatment, compared to the control group, the appearance of radiation dermatitis and scarring was alleviated, and hair growth was restored (Figure 5G).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel G",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel G",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Histological analysis revealed better epithelial continuity in the PBVac + Light group (Figure 5H) and increased skin appendages, including hair follicles and blood vessels, along with enhanced collagen accumulation by day 28.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel H",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel H",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "In terms of antitumor activity, PBVac showed a minimal 1.5-fold increase in tumor volume compared to a 40-fold increase in the PBS and PB nanozyme groups (Figure 5I).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel I",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel I",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Post-PTT, most cancer cells exhibited shrinkage and necrosis (Figure 6A).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Under the influence of CD47 receptor-mediated targeting by nGO-COS, the nanocomposite material achieved a high uptake intensity in melanoma cells at a relatively low concentration (5 μg/mL) (Figure 6C).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "This indicates a high photothermal conversion efficiency, which is proportional to concentration and laser power intensity, making it suitable for use as a thermotherapeutic agent (Figure 6H).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel H",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel H",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "At the same drug concentration, the number of cancer cells killed after treatment with free DTIC was significantly lower compared to nGO-COS-CD47/DTIC (Figure 6D).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The researchers constructed the nanoplatforms HA-PAMAM-COOH-TMZ and HA-PAMAM-COOH-ICG by loading temozolomide and indocyanine green onto HA-modified carboxylated polyamidoamine, respectively, for combined chemotherapy and PTT/PDT (Figure 6B).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Under near-infrared light irradiation, as the concentration of ICG increased, the temperature of HPCI rose, reaching over 50°C at its peak (Figure 6E).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel E",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel E",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Moreover, at the same concentration, the heating capacity of HPCI was similar to that of free ICG (Figure 6F), while the production of ROS was higher than that of free ICG (Figure 6G), indicating that HPCI has a good foundational capability for synergistic PTT/PDT treatment.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel F",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel G",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel F",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel G",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In the PAI validation experiments, untreated control cells showed the lowest PA amplitude, while cells incubated with MnO2 nanotubes exhibited the highest PA amplitude, which was 2.2 times higher than the control group and showed the slowest decrease in amplitude (Figure 7G).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel G",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel G",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "In PAI, the stability of nanomaterials is a non-negligible issue, in order to study the stability of MnO2 nanotubes in repetitive imaging, the researchers detected the PA signals of 2 mg/mL manganese dioxide nanotubes at 100, 2000, 4000, 8000 and 16000 laser pulses, respectively, and the results showed that there was no significant difference in the PA signals obtained at different laser pulses, and the this also proves the good stability of MnO2 nanotubes in PAI. (Figure 7A).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The experiments also ruled out the dilution effect caused by tumor growth as a factor for the reduction in PA signal, confirming the sensitivity of MnO2 nanotubes as PA probes for PAI (Figure 7B and C).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel B",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The researchers also conducted in vivo experiments and found that AuNRs could specifically accumulate at tumor sites, acting as contrast agents in PAI(Figure 7E).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel E",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel E",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Continued.Figure 8.\n\n(A) Histological staining of organs in mice 25 days after treatment.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "When PBP and BP contrast agents were separately injected intravenously into tumor-bearing mice, the mice injected with PBP exhibited higher contrast in the tumor region on PAI, with a duration of up to 24 hours (Figure 8B).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel B",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel B",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The maximum cell apoptosis rate reached 74% (Figure 8C and D).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel C",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "A noticeable infiltration of CD8+ cells in the tumor site was observed (Figure 8E–G).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel E",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Phototherapy applied to skin cancer can function through PDT, PTT, and PA (Figure 1), offering both diagnostic and therapeutic effects.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Additionally, improving platform structural compatibility to achieve multifunctional effects simultaneously, enhancing therapeutic outcomes, and increasing indications is also a viable strategy (Figure 4G).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel G",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel G",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "These effects are harnessed for targeted tumor ablation, often with minimal damage to surrounding healthy tissues (Figure 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Different tumors have varying levels of infiltration into the skin tissue, ranging from superficial in squamous cell carcinoma to deeper in melanoma (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Phototherapy is primarily categorized into PDT, PTT, and PAT, or the combined treatment of PDT and PTT,9,10 each with distinct mechanisms (Figure 1C).11 In addition, other research teams have utilized vibronic-driven action to activate aminocyanines under near-infrared light, causing membrane disruption and subsequently inducing cell death.12 Local drug application minimizes toxic side effects on normal cells, while the light-stimulated response ensures precise, targeted treatment, reducing drug waste.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In contrast, laser ablation techniques that do not include PTT drugs have already begun to have already begun to see widely clinical applications.14\n\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The development of skin cancer is influenced by a combination of factors, but ultraviolet (UV) radiation from sunlight is the primary pathogenic factor for the occurrence and progression of skin cancer globally.16\nMelanoma and non-melanoma skin tumors account for more than one-third of all malignant tumors, making them the most common tumor types.16 Skin cancer is classified based on the cells of origin and clinical features and can be divided into NMSC and MSC.17 NMSC includes all non-melanoma malignant tumors affecting the skin.18 In epidemiological contexts, however, NMSC specifically refers to keratinocyte carcinoma, which includes BCC, SCC, and Cutaneous T-cell lymphoma (CTCL), as these account for 99% of this group of tumors (Figure 1B).19MSC\nMelanoma is considered a multifactorial disease and has the highest mutation rate among all cancers.20 Based on the common mutation patterns in melanoma, melanoma can be categorized into four subtypes. (i) BRAF-mutant (52% present), with BRAF mutations being the largest genomic subtype of melanoma.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "It was incubated with the oncolytic bacterium (Clostridium butyricum) to produce engineered oncolytic bacteria, which were then validated using a mouse model of malignant melanoma (Figure 2A).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Microscopic imaging and real-time monitoring results showed that the targeted Au@MTM-HA had the strongest ROS generation capability (Figure 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Compared to free Ce6, both PPC and PPC@HA enhanced the cellular uptake efficiency in B16 cells (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Thanks to HA-mediated targeted delivery and HA degradation-mediated charge reversal, the chemo-photodynamic combination therapy of PPC@HA+laser showed the most effective anti-tumor efficacy with the lowest tumor growth rate(Figure 2D and E).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel D",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Additionally, “hydrophobic and hydrophilic pockets” were constructed around the UCNPs, with hydrophobic PS (Ce6) and hydrophilic peroxidase (CTA) loaded into them (Figure 2G).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel G",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel G",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "After staining the cells with mitochondrial fluorescent dyes, it was observed that CTPP-modified NPs exhibited superior targeting and accumulation in the mitochondrial matrix compared to non-modified samples (Figure 2F).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel F",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel F",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Additionally, in vivo anticancer experiments revealed that tumors treated with the Ru4 + laser group significantly extended the survival time of mice (Figure 3C) and showed no significant dark toxicity (organ damage) (Figure 3E).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel E",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel E",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Although the absorption efficiency varied among different cell types, the PSs encapsulated within the cubic NPs showed enhanced cellular internalization and consequently stronger fluorescence signals (Figure 3A and B).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Surface markers on immune cells were stained 9 days after irradiation (Figure 3F).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel F",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel F",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "This leads to a higher level of infiltration of CD8 and CD4 T cells into tumors and lymph nodes (Figure 3G), which can kill tumor cells.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel G",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel G",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Ce6 generates ROS under light stimulation, which not only exerts PDT effects but also cleaves the disulfide bond to release CTX for chemotherapeutic action (Figure 3D).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel D",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel D",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "At the end of the treatment, tumor sections were stained with hematoxylin-eosin (H&E) for histological analysis, and the results showed that the synergistic treatment of psTKdC NAs and laser irradiation was effective in inducing apoptosis and necrosis of intratumor cells.(Figure 3H).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel H",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel H",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Additionally, terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling immunohistochemical staining confirmed the excellent combination of chemotherapy and photodynamic activity (Figure 3I).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel I",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel I",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The average inhibition rates for the NPs group, laser group, and NPs + laser group were 6%, 26%, and 57%, respectively (Figure 4A).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Melanin@RBC-M with a 1:1 weight ratio of red blood cell membrane to MCF-7 membrane proteins showed an increase in tumor temperature from 29.6°C to 54.0°C within 10 minutes (Figure 4D).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel D",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel D",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Compared to the weak tumor suppression ability of bare melanin NPs, the 1:1 group of Melanin@RBC-M demonstrated complete tumor elimination (Figure 4E and F).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel E",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The researchers conducted an in vitro evaluation of transdermal performance (Figure 4B).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The penetration efficiency of (+)T-SiDs was significantly higher than that of (+)SiDs (without TD), and the fluorescence intensity of the skin sections was also markedly stronger than the latter (Figure 4C), demonstrating higher transdermal permeability.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel C",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel C",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "However, the temperatures of the transdermally treated group increased gradually to 46°C, which was higher than that of the injected group at 43°C, and the temperatures of the injected group were higher than that of the injected group. (Figure 4D and E).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel D",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Twenty-four hours after treatment, tumor sections stained for analysis showed varying degrees of cell lysis and disruption, leading to significant necrosis and apoptosis of tumor cells (Figure 4F).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel F",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel F",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Ho et al155 developed a nanographene oxide-hyaluronic acid conjugate (NGO-HA) for photothermal ablation therapy of MSC (Figure 5A).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "When the concentration of NGO-HA exceeds 250 μg/mL, NIR irradiation for 10 minutes can raise the temperature of the NGO-HA solution by approximately 40°C (Figure 5B), sufficient to induce a photothermal effect.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Due to the transdermal properties of HA derivatives, NGO-HA can significantly penetrate the compromised cancerous skin barrier (Figure 5C).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel C",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel C",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "However, wound healing and skin regeneration following traditional skin tumor surgery and chronic bacterial infection-induced wounds remain a challenge.157 The formation of chronic wounds is closely related to the presence of pathogenic bacteria in the postoperative skin defect.158 Timely application of antibiotics can reduce bacterial infection; however, the emergence of multidrug-resistant (MDR) bacteria increases the risk of chronic wounds.159 Wang et al156 developed a novel double-crosslinked BMH hydrogel (Figure 5D), which is injectable, adhesive, redox/photo-responsive, and has inherent antibacterial properties.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel D",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel D",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Furthermore, its antibacterial effect lasted longer, demonstrating a 100% antibacterial rate 14 days post-treatment (Figure 5E).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Additionally, the wound defects in the BMH hydrogel group almost disappeared by day 14 (Figure 5F).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel F",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel F",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "After PBVac + Light treatment, compared to the control group, the appearance of radiation dermatitis and scarring was alleviated, and hair growth was restored (Figure 5G).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel G",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel G",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Histological analysis revealed better epithelial continuity in the PBVac + Light group (Figure 5H) and increased skin appendages, including hair follicles and blood vessels, along with enhanced collagen accumulation by day 28.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel H",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel H",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "In terms of antitumor activity, PBVac showed a minimal 1.5-fold increase in tumor volume compared to a 40-fold increase in the PBS and PB nanozyme groups (Figure 5I).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel I",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel I",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Post-PTT, most cancer cells exhibited shrinkage and necrosis (Figure 6A).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Under the influence of CD47 receptor-mediated targeting by nGO-COS, the nanocomposite material achieved a high uptake intensity in melanoma cells at a relatively low concentration (5 μg/mL) (Figure 6C).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "This indicates a high photothermal conversion efficiency, which is proportional to concentration and laser power intensity, making it suitable for use as a thermotherapeutic agent (Figure 6H).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel H",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel H",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "At the same drug concentration, the number of cancer cells killed after treatment with free DTIC was significantly lower compared to nGO-COS-CD47/DTIC (Figure 6D).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The researchers constructed the nanoplatforms HA-PAMAM-COOH-TMZ and HA-PAMAM-COOH-ICG by loading temozolomide and indocyanine green onto HA-modified carboxylated polyamidoamine, respectively, for combined chemotherapy and PTT/PDT (Figure 6B).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Under near-infrared light irradiation, as the concentration of ICG increased, the temperature of HPCI rose, reaching over 50°C at its peak (Figure 6E).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel E",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel E",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Moreover, at the same concentration, the heating capacity of HPCI was similar to that of free ICG (Figure 6F), while the production of ROS was higher than that of free ICG (Figure 6G), indicating that HPCI has a good foundational capability for synergistic PTT/PDT treatment.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel F",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel G",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel F",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel G",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In the PAI validation experiments, untreated control cells showed the lowest PA amplitude, while cells incubated with MnO2 nanotubes exhibited the highest PA amplitude, which was 2.2 times higher than the control group and showed the slowest decrease in amplitude (Figure 7G).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel G",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel G",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "In PAI, the stability of nanomaterials is a non-negligible issue, in order to study the stability of MnO2 nanotubes in repetitive imaging, the researchers detected the PA signals of 2 mg/mL manganese dioxide nanotubes at 100, 2000, 4000, 8000 and 16000 laser pulses, respectively, and the results showed that there was no significant difference in the PA signals obtained at different laser pulses, and the this also proves the good stability of MnO2 nanotubes in PAI. (Figure 7A).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The experiments also ruled out the dilution effect caused by tumor growth as a factor for the reduction in PA signal, confirming the sensitivity of MnO2 nanotubes as PA probes for PAI (Figure 7B and C).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel B",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The researchers also conducted in vivo experiments and found that AuNRs could specifically accumulate at tumor sites, acting as contrast agents in PAI(Figure 7E).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel E",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel E",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Continued.Figure 8.\n\n(A) Histological staining of organs in mice 25 days after treatment.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "When PBP and BP contrast agents were separately injected intravenously into tumor-bearing mice, the mice injected with PBP exhibited higher contrast in the tumor region on PAI, with a duration of up to 24 hours (Figure 8B).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel B",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel B",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The maximum cell apoptosis rate reached 74% (Figure 8C and D).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel C",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "A noticeable infiltration of CD8+ cells in the tumor site was observed (Figure 8E–G).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel E",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Phototherapy applied to skin cancer can function through PDT, PTT, and PA (Figure 1), offering both diagnostic and therapeutic effects.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Additionally, improving platform structural compatibility to achieve multifunctional effects simultaneously, enhancing therapeutic outcomes, and increasing indications is also a viable strategy (Figure 4G).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel G",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel G",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "These effects are harnessed for targeted tumor ablation, often with minimal damage to surrounding healthy tissues (Figure 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Different tumors have varying levels of infiltration into the skin tissue, ranging from superficial in squamous cell carcinoma to deeper in melanoma (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Phototherapy is primarily categorized into PDT, PTT, and PAT, or the combined treatment of PDT and PTT,9,10 each with distinct mechanisms (Figure 1C).11 In addition, other research teams have utilized vibronic-driven action to activate aminocyanines under near-infrared light, causing membrane disruption and subsequently inducing cell death.12 Local drug application minimizes toxic side effects on normal cells, while the light-stimulated response ensures precise, targeted treatment, reducing drug waste.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In contrast, laser ablation techniques that do not include PTT drugs have already begun to have already begun to see widely clinical applications.14\n\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The development of skin cancer is influenced by a combination of factors, but ultraviolet (UV) radiation from sunlight is the primary pathogenic factor for the occurrence and progression of skin cancer globally.16\nMelanoma and non-melanoma skin tumors account for more than one-third of all malignant tumors, making them the most common tumor types.16 Skin cancer is classified based on the cells of origin and clinical features and can be divided into NMSC and MSC.17 NMSC includes all non-melanoma malignant tumors affecting the skin.18 In epidemiological contexts, however, NMSC specifically refers to keratinocyte carcinoma, which includes BCC, SCC, and Cutaneous T-cell lymphoma (CTCL), as these account for 99% of this group of tumors (Figure 1B).19MSC\nMelanoma is considered a multifactorial disease and has the highest mutation rate among all cancers.20 Based on the common mutation patterns in melanoma, melanoma can be categorized into four subtypes. (i) BRAF-mutant (52% present), with BRAF mutations being the largest genomic subtype of melanoma.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "It was incubated with the oncolytic bacterium (Clostridium butyricum) to produce engineered oncolytic bacteria, which were then validated using a mouse model of malignant melanoma (Figure 2A).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Microscopic imaging and real-time monitoring results showed that the targeted Au@MTM-HA had the strongest ROS generation capability (Figure 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Compared to free Ce6, both PPC and PPC@HA enhanced the cellular uptake efficiency in B16 cells (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Thanks to HA-mediated targeted delivery and HA degradation-mediated charge reversal, the chemo-photodynamic combination therapy of PPC@HA+laser showed the most effective anti-tumor efficacy with the lowest tumor growth rate(Figure 2D and E).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel D",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Additionally, “hydrophobic and hydrophilic pockets” were constructed around the UCNPs, with hydrophobic PS (Ce6) and hydrophilic peroxidase (CTA) loaded into them (Figure 2G).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel G",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel G",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "After staining the cells with mitochondrial fluorescent dyes, it was observed that CTPP-modified NPs exhibited superior targeting and accumulation in the mitochondrial matrix compared to non-modified samples (Figure 2F).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel F",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel F",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Additionally, in vivo anticancer experiments revealed that tumors treated with the Ru4 + laser group significantly extended the survival time of mice (Figure 3C) and showed no significant dark toxicity (organ damage) (Figure 3E).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel E",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel E",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Although the absorption efficiency varied among different cell types, the PSs encapsulated within the cubic NPs showed enhanced cellular internalization and consequently stronger fluorescence signals (Figure 3A and B).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Surface markers on immune cells were stained 9 days after irradiation (Figure 3F).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel F",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel F",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "This leads to a higher level of infiltration of CD8 and CD4 T cells into tumors and lymph nodes (Figure 3G), which can kill tumor cells.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel G",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel G",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Ce6 generates ROS under light stimulation, which not only exerts PDT effects but also cleaves the disulfide bond to release CTX for chemotherapeutic action (Figure 3D).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel D",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel D",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "At the end of the treatment, tumor sections were stained with hematoxylin-eosin (H&E) for histological analysis, and the results showed that the synergistic treatment of psTKdC NAs and laser irradiation was effective in inducing apoptosis and necrosis of intratumor cells.(Figure 3H).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel H",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel H",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Additionally, terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling immunohistochemical staining confirmed the excellent combination of chemotherapy and photodynamic activity (Figure 3I).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel I",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel I",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The average inhibition rates for the NPs group, laser group, and NPs + laser group were 6%, 26%, and 57%, respectively (Figure 4A).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Melanin@RBC-M with a 1:1 weight ratio of red blood cell membrane to MCF-7 membrane proteins showed an increase in tumor temperature from 29.6°C to 54.0°C within 10 minutes (Figure 4D).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel D",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel D",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Compared to the weak tumor suppression ability of bare melanin NPs, the 1:1 group of Melanin@RBC-M demonstrated complete tumor elimination (Figure 4E and F).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel E",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The researchers conducted an in vitro evaluation of transdermal performance (Figure 4B).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The penetration efficiency of (+)T-SiDs was significantly higher than that of (+)SiDs (without TD), and the fluorescence intensity of the skin sections was also markedly stronger than the latter (Figure 4C), demonstrating higher transdermal permeability.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel C",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel C",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "However, the temperatures of the transdermally treated group increased gradually to 46°C, which was higher than that of the injected group at 43°C, and the temperatures of the injected group were higher than that of the injected group. (Figure 4D and E).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel D",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Twenty-four hours after treatment, tumor sections stained for analysis showed varying degrees of cell lysis and disruption, leading to significant necrosis and apoptosis of tumor cells (Figure 4F).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel F",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel F",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Ho et al155 developed a nanographene oxide-hyaluronic acid conjugate (NGO-HA) for photothermal ablation therapy of MSC (Figure 5A).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "When the concentration of NGO-HA exceeds 250 μg/mL, NIR irradiation for 10 minutes can raise the temperature of the NGO-HA solution by approximately 40°C (Figure 5B), sufficient to induce a photothermal effect.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Due to the transdermal properties of HA derivatives, NGO-HA can significantly penetrate the compromised cancerous skin barrier (Figure 5C).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel C",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel C",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "However, wound healing and skin regeneration following traditional skin tumor surgery and chronic bacterial infection-induced wounds remain a challenge.157 The formation of chronic wounds is closely related to the presence of pathogenic bacteria in the postoperative skin defect.158 Timely application of antibiotics can reduce bacterial infection; however, the emergence of multidrug-resistant (MDR) bacteria increases the risk of chronic wounds.159 Wang et al156 developed a novel double-crosslinked BMH hydrogel (Figure 5D), which is injectable, adhesive, redox/photo-responsive, and has inherent antibacterial properties.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel D",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel D",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Furthermore, its antibacterial effect lasted longer, demonstrating a 100% antibacterial rate 14 days post-treatment (Figure 5E).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Additionally, the wound defects in the BMH hydrogel group almost disappeared by day 14 (Figure 5F).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel F",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel F",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "After PBVac + Light treatment, compared to the control group, the appearance of radiation dermatitis and scarring was alleviated, and hair growth was restored (Figure 5G).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel G",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel G",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Histological analysis revealed better epithelial continuity in the PBVac + Light group (Figure 5H) and increased skin appendages, including hair follicles and blood vessels, along with enhanced collagen accumulation by day 28.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel H",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel H",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "In terms of antitumor activity, PBVac showed a minimal 1.5-fold increase in tumor volume compared to a 40-fold increase in the PBS and PB nanozyme groups (Figure 5I).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel I",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel I",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Post-PTT, most cancer cells exhibited shrinkage and necrosis (Figure 6A).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Under the influence of CD47 receptor-mediated targeting by nGO-COS, the nanocomposite material achieved a high uptake intensity in melanoma cells at a relatively low concentration (5 μg/mL) (Figure 6C).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "This indicates a high photothermal conversion efficiency, which is proportional to concentration and laser power intensity, making it suitable for use as a thermotherapeutic agent (Figure 6H).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel H",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel H",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "At the same drug concentration, the number of cancer cells killed after treatment with free DTIC was significantly lower compared to nGO-COS-CD47/DTIC (Figure 6D).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The researchers constructed the nanoplatforms HA-PAMAM-COOH-TMZ and HA-PAMAM-COOH-ICG by loading temozolomide and indocyanine green onto HA-modified carboxylated polyamidoamine, respectively, for combined chemotherapy and PTT/PDT (Figure 6B).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Under near-infrared light irradiation, as the concentration of ICG increased, the temperature of HPCI rose, reaching over 50°C at its peak (Figure 6E).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel E",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel E",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Moreover, at the same concentration, the heating capacity of HPCI was similar to that of free ICG (Figure 6F), while the production of ROS was higher than that of free ICG (Figure 6G), indicating that HPCI has a good foundational capability for synergistic PTT/PDT treatment.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel F",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel G",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel F",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel G",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In the PAI validation experiments, untreated control cells showed the lowest PA amplitude, while cells incubated with MnO2 nanotubes exhibited the highest PA amplitude, which was 2.2 times higher than the control group and showed the slowest decrease in amplitude (Figure 7G).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel G",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel G",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "In PAI, the stability of nanomaterials is a non-negligible issue, in order to study the stability of MnO2 nanotubes in repetitive imaging, the researchers detected the PA signals of 2 mg/mL manganese dioxide nanotubes at 100, 2000, 4000, 8000 and 16000 laser pulses, respectively, and the results showed that there was no significant difference in the PA signals obtained at different laser pulses, and the this also proves the good stability of MnO2 nanotubes in PAI. (Figure 7A).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The experiments also ruled out the dilution effect caused by tumor growth as a factor for the reduction in PA signal, confirming the sensitivity of MnO2 nanotubes as PA probes for PAI (Figure 7B and C).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel B",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The researchers also conducted in vivo experiments and found that AuNRs could specifically accumulate at tumor sites, acting as contrast agents in PAI(Figure 7E).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel E",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel E",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Continued.Figure 8.\n\n(A) Histological staining of organs in mice 25 days after treatment.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "When PBP and BP contrast agents were separately injected intravenously into tumor-bearing mice, the mice injected with PBP exhibited higher contrast in the tumor region on PAI, with a duration of up to 24 hours (Figure 8B).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel B",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel B",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The maximum cell apoptosis rate reached 74% (Figure 8C and D).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel C",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "A noticeable infiltration of CD8+ cells in the tumor site was observed (Figure 8E–G).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel E",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Phototherapy applied to skin cancer can function through PDT, PTT, and PA (Figure 1), offering both diagnostic and therapeutic effects.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Additionally, improving platform structural compatibility to achieve multifunctional effects simultaneously, enhancing therapeutic outcomes, and increasing indications is also a viable strategy (Figure 4G).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel G",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel G",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "These effects are harnessed for targeted tumor ablation, often with minimal damage to surrounding healthy tissues (Figure 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Different tumors have varying levels of infiltration into the skin tissue, ranging from superficial in squamous cell carcinoma to deeper in melanoma (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Phototherapy is primarily categorized into PDT, PTT, and PAT, or the combined treatment of PDT and PTT,9,10 each with distinct mechanisms (Figure 1C).11 In addition, other research teams have utilized vibronic-driven action to activate aminocyanines under near-infrared light, causing membrane disruption and subsequently inducing cell death.12 Local drug application minimizes toxic side effects on normal cells, while the light-stimulated response ensures precise, targeted treatment, reducing drug waste.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In contrast, laser ablation techniques that do not include PTT drugs have already begun to have already begun to see widely clinical applications.14\n\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The development of skin cancer is influenced by a combination of factors, but ultraviolet (UV) radiation from sunlight is the primary pathogenic factor for the occurrence and progression of skin cancer globally.16\nMelanoma and non-melanoma skin tumors account for more than one-third of all malignant tumors, making them the most common tumor types.16 Skin cancer is classified based on the cells of origin and clinical features and can be divided into NMSC and MSC.17 NMSC includes all non-melanoma malignant tumors affecting the skin.18 In epidemiological contexts, however, NMSC specifically refers to keratinocyte carcinoma, which includes BCC, SCC, and Cutaneous T-cell lymphoma (CTCL), as these account for 99% of this group of tumors (Figure 1B).19MSC\nMelanoma is considered a multifactorial disease and has the highest mutation rate among all cancers.20 Based on the common mutation patterns in melanoma, melanoma can be categorized into four subtypes. (i) BRAF-mutant (52% present), with BRAF mutations being the largest genomic subtype of melanoma.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "It was incubated with the oncolytic bacterium (Clostridium butyricum) to produce engineered oncolytic bacteria, which were then validated using a mouse model of malignant melanoma (Figure 2A).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Microscopic imaging and real-time monitoring results showed that the targeted Au@MTM-HA had the strongest ROS generation capability (Figure 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Compared to free Ce6, both PPC and PPC@HA enhanced the cellular uptake efficiency in B16 cells (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Thanks to HA-mediated targeted delivery and HA degradation-mediated charge reversal, the chemo-photodynamic combination therapy of PPC@HA+laser showed the most effective anti-tumor efficacy with the lowest tumor growth rate(Figure 2D and E).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel D",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Additionally, “hydrophobic and hydrophilic pockets” were constructed around the UCNPs, with hydrophobic PS (Ce6) and hydrophilic peroxidase (CTA) loaded into them (Figure 2G).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel G",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel G",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "After staining the cells with mitochondrial fluorescent dyes, it was observed that CTPP-modified NPs exhibited superior targeting and accumulation in the mitochondrial matrix compared to non-modified samples (Figure 2F).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel F",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel F",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Additionally, in vivo anticancer experiments revealed that tumors treated with the Ru4 + laser group significantly extended the survival time of mice (Figure 3C) and showed no significant dark toxicity (organ damage) (Figure 3E).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel E",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel E",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Although the absorption efficiency varied among different cell types, the PSs encapsulated within the cubic NPs showed enhanced cellular internalization and consequently stronger fluorescence signals (Figure 3A and B).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Surface markers on immune cells were stained 9 days after irradiation (Figure 3F).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel F",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel F",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "This leads to a higher level of infiltration of CD8 and CD4 T cells into tumors and lymph nodes (Figure 3G), which can kill tumor cells.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel G",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel G",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Ce6 generates ROS under light stimulation, which not only exerts PDT effects but also cleaves the disulfide bond to release CTX for chemotherapeutic action (Figure 3D).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel D",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel D",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "At the end of the treatment, tumor sections were stained with hematoxylin-eosin (H&E) for histological analysis, and the results showed that the synergistic treatment of psTKdC NAs and laser irradiation was effective in inducing apoptosis and necrosis of intratumor cells.(Figure 3H).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel H",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel H",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Additionally, terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling immunohistochemical staining confirmed the excellent combination of chemotherapy and photodynamic activity (Figure 3I).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel I",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel I",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The average inhibition rates for the NPs group, laser group, and NPs + laser group were 6%, 26%, and 57%, respectively (Figure 4A).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Melanin@RBC-M with a 1:1 weight ratio of red blood cell membrane to MCF-7 membrane proteins showed an increase in tumor temperature from 29.6°C to 54.0°C within 10 minutes (Figure 4D).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel D",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel D",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Compared to the weak tumor suppression ability of bare melanin NPs, the 1:1 group of Melanin@RBC-M demonstrated complete tumor elimination (Figure 4E and F).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel E",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The researchers conducted an in vitro evaluation of transdermal performance (Figure 4B).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The penetration efficiency of (+)T-SiDs was significantly higher than that of (+)SiDs (without TD), and the fluorescence intensity of the skin sections was also markedly stronger than the latter (Figure 4C), demonstrating higher transdermal permeability.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel C",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel C",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "However, the temperatures of the transdermally treated group increased gradually to 46°C, which was higher than that of the injected group at 43°C, and the temperatures of the injected group were higher than that of the injected group. (Figure 4D and E).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel D",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Twenty-four hours after treatment, tumor sections stained for analysis showed varying degrees of cell lysis and disruption, leading to significant necrosis and apoptosis of tumor cells (Figure 4F).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel F",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel F",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Ho et al155 developed a nanographene oxide-hyaluronic acid conjugate (NGO-HA) for photothermal ablation therapy of MSC (Figure 5A).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "When the concentration of NGO-HA exceeds 250 μg/mL, NIR irradiation for 10 minutes can raise the temperature of the NGO-HA solution by approximately 40°C (Figure 5B), sufficient to induce a photothermal effect.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Due to the transdermal properties of HA derivatives, NGO-HA can significantly penetrate the compromised cancerous skin barrier (Figure 5C).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel C",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel C",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "However, wound healing and skin regeneration following traditional skin tumor surgery and chronic bacterial infection-induced wounds remain a challenge.157 The formation of chronic wounds is closely related to the presence of pathogenic bacteria in the postoperative skin defect.158 Timely application of antibiotics can reduce bacterial infection; however, the emergence of multidrug-resistant (MDR) bacteria increases the risk of chronic wounds.159 Wang et al156 developed a novel double-crosslinked BMH hydrogel (Figure 5D), which is injectable, adhesive, redox/photo-responsive, and has inherent antibacterial properties.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel D",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel D",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Furthermore, its antibacterial effect lasted longer, demonstrating a 100% antibacterial rate 14 days post-treatment (Figure 5E).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Additionally, the wound defects in the BMH hydrogel group almost disappeared by day 14 (Figure 5F).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel F",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel F",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "After PBVac + Light treatment, compared to the control group, the appearance of radiation dermatitis and scarring was alleviated, and hair growth was restored (Figure 5G).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel G",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel G",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Histological analysis revealed better epithelial continuity in the PBVac + Light group (Figure 5H) and increased skin appendages, including hair follicles and blood vessels, along with enhanced collagen accumulation by day 28.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel H",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel H",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "In terms of antitumor activity, PBVac showed a minimal 1.5-fold increase in tumor volume compared to a 40-fold increase in the PBS and PB nanozyme groups (Figure 5I).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel I",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel I",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Post-PTT, most cancer cells exhibited shrinkage and necrosis (Figure 6A).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Under the influence of CD47 receptor-mediated targeting by nGO-COS, the nanocomposite material achieved a high uptake intensity in melanoma cells at a relatively low concentration (5 μg/mL) (Figure 6C).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "This indicates a high photothermal conversion efficiency, which is proportional to concentration and laser power intensity, making it suitable for use as a thermotherapeutic agent (Figure 6H).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel H",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel H",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "At the same drug concentration, the number of cancer cells killed after treatment with free DTIC was significantly lower compared to nGO-COS-CD47/DTIC (Figure 6D).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The researchers constructed the nanoplatforms HA-PAMAM-COOH-TMZ and HA-PAMAM-COOH-ICG by loading temozolomide and indocyanine green onto HA-modified carboxylated polyamidoamine, respectively, for combined chemotherapy and PTT/PDT (Figure 6B).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Under near-infrared light irradiation, as the concentration of ICG increased, the temperature of HPCI rose, reaching over 50°C at its peak (Figure 6E).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel E",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel E",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Moreover, at the same concentration, the heating capacity of HPCI was similar to that of free ICG (Figure 6F), while the production of ROS was higher than that of free ICG (Figure 6G), indicating that HPCI has a good foundational capability for synergistic PTT/PDT treatment.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel F",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel G",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel F",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel G",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In the PAI validation experiments, untreated control cells showed the lowest PA amplitude, while cells incubated with MnO2 nanotubes exhibited the highest PA amplitude, which was 2.2 times higher than the control group and showed the slowest decrease in amplitude (Figure 7G).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel G",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel G",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "In PAI, the stability of nanomaterials is a non-negligible issue, in order to study the stability of MnO2 nanotubes in repetitive imaging, the researchers detected the PA signals of 2 mg/mL manganese dioxide nanotubes at 100, 2000, 4000, 8000 and 16000 laser pulses, respectively, and the results showed that there was no significant difference in the PA signals obtained at different laser pulses, and the this also proves the good stability of MnO2 nanotubes in PAI. (Figure 7A).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The experiments also ruled out the dilution effect caused by tumor growth as a factor for the reduction in PA signal, confirming the sensitivity of MnO2 nanotubes as PA probes for PAI (Figure 7B and C).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel B",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The researchers also conducted in vivo experiments and found that AuNRs could specifically accumulate at tumor sites, acting as contrast agents in PAI(Figure 7E).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel E",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel E",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Continued.Figure 8.\n\n(A) Histological staining of organs in mice 25 days after treatment.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "When PBP and BP contrast agents were separately injected intravenously into tumor-bearing mice, the mice injected with PBP exhibited higher contrast in the tumor region on PAI, with a duration of up to 24 hours (Figure 8B).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel B",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel B",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The maximum cell apoptosis rate reached 74% (Figure 8C and D).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel C",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "A noticeable infiltration of CD8+ cells in the tumor site was observed (Figure 8E–G).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel E",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Phototherapy applied to skin cancer can function through PDT, PTT, and PA (Figure 1), offering both diagnostic and therapeutic effects.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Additionally, improving platform structural compatibility to achieve multifunctional effects simultaneously, enhancing therapeutic outcomes, and increasing indications is also a viable strategy (Figure 4G).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel G",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel G",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "These effects are harnessed for targeted tumor ablation, often with minimal damage to surrounding healthy tissues (Figure 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Different tumors have varying levels of infiltration into the skin tissue, ranging from superficial in squamous cell carcinoma to deeper in melanoma (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Phototherapy is primarily categorized into PDT, PTT, and PAT, or the combined treatment of PDT and PTT,9,10 each with distinct mechanisms (Figure 1C).11 In addition, other research teams have utilized vibronic-driven action to activate aminocyanines under near-infrared light, causing membrane disruption and subsequently inducing cell death.12 Local drug application minimizes toxic side effects on normal cells, while the light-stimulated response ensures precise, targeted treatment, reducing drug waste.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In contrast, laser ablation techniques that do not include PTT drugs have already begun to have already begun to see widely clinical applications.14\n\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The development of skin cancer is influenced by a combination of factors, but ultraviolet (UV) radiation from sunlight is the primary pathogenic factor for the occurrence and progression of skin cancer globally.16\nMelanoma and non-melanoma skin tumors account for more than one-third of all malignant tumors, making them the most common tumor types.16 Skin cancer is classified based on the cells of origin and clinical features and can be divided into NMSC and MSC.17 NMSC includes all non-melanoma malignant tumors affecting the skin.18 In epidemiological contexts, however, NMSC specifically refers to keratinocyte carcinoma, which includes BCC, SCC, and Cutaneous T-cell lymphoma (CTCL), as these account for 99% of this group of tumors (Figure 1B).19MSC\nMelanoma is considered a multifactorial disease and has the highest mutation rate among all cancers.20 Based on the common mutation patterns in melanoma, melanoma can be categorized into four subtypes. (i) BRAF-mutant (52% present), with BRAF mutations being the largest genomic subtype of melanoma.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "It was incubated with the oncolytic bacterium (Clostridium butyricum) to produce engineered oncolytic bacteria, which were then validated using a mouse model of malignant melanoma (Figure 2A).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Microscopic imaging and real-time monitoring results showed that the targeted Au@MTM-HA had the strongest ROS generation capability (Figure 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Compared to free Ce6, both PPC and PPC@HA enhanced the cellular uptake efficiency in B16 cells (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Thanks to HA-mediated targeted delivery and HA degradation-mediated charge reversal, the chemo-photodynamic combination therapy of PPC@HA+laser showed the most effective anti-tumor efficacy with the lowest tumor growth rate(Figure 2D and E).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel D",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Additionally, “hydrophobic and hydrophilic pockets” were constructed around the UCNPs, with hydrophobic PS (Ce6) and hydrophilic peroxidase (CTA) loaded into them (Figure 2G).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel G",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel G",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "After staining the cells with mitochondrial fluorescent dyes, it was observed that CTPP-modified NPs exhibited superior targeting and accumulation in the mitochondrial matrix compared to non-modified samples (Figure 2F).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel F",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel F",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Additionally, in vivo anticancer experiments revealed that tumors treated with the Ru4 + laser group significantly extended the survival time of mice (Figure 3C) and showed no significant dark toxicity (organ damage) (Figure 3E).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel E",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel E",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Although the absorption efficiency varied among different cell types, the PSs encapsulated within the cubic NPs showed enhanced cellular internalization and consequently stronger fluorescence signals (Figure 3A and B).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Surface markers on immune cells were stained 9 days after irradiation (Figure 3F).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel F",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel F",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "This leads to a higher level of infiltration of CD8 and CD4 T cells into tumors and lymph nodes (Figure 3G), which can kill tumor cells.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel G",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel G",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Ce6 generates ROS under light stimulation, which not only exerts PDT effects but also cleaves the disulfide bond to release CTX for chemotherapeutic action (Figure 3D).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel D",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel D",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "At the end of the treatment, tumor sections were stained with hematoxylin-eosin (H&E) for histological analysis, and the results showed that the synergistic treatment of psTKdC NAs and laser irradiation was effective in inducing apoptosis and necrosis of intratumor cells.(Figure 3H).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel H",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel H",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Additionally, terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling immunohistochemical staining confirmed the excellent combination of chemotherapy and photodynamic activity (Figure 3I).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel I",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel I",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The average inhibition rates for the NPs group, laser group, and NPs + laser group were 6%, 26%, and 57%, respectively (Figure 4A).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Melanin@RBC-M with a 1:1 weight ratio of red blood cell membrane to MCF-7 membrane proteins showed an increase in tumor temperature from 29.6°C to 54.0°C within 10 minutes (Figure 4D).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel D",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel D",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Compared to the weak tumor suppression ability of bare melanin NPs, the 1:1 group of Melanin@RBC-M demonstrated complete tumor elimination (Figure 4E and F).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel E",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The researchers conducted an in vitro evaluation of transdermal performance (Figure 4B).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The penetration efficiency of (+)T-SiDs was significantly higher than that of (+)SiDs (without TD), and the fluorescence intensity of the skin sections was also markedly stronger than the latter (Figure 4C), demonstrating higher transdermal permeability.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel C",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel C",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "However, the temperatures of the transdermally treated group increased gradually to 46°C, which was higher than that of the injected group at 43°C, and the temperatures of the injected group were higher than that of the injected group. (Figure 4D and E).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel D",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Twenty-four hours after treatment, tumor sections stained for analysis showed varying degrees of cell lysis and disruption, leading to significant necrosis and apoptosis of tumor cells (Figure 4F).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel F",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel F",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Ho et al155 developed a nanographene oxide-hyaluronic acid conjugate (NGO-HA) for photothermal ablation therapy of MSC (Figure 5A).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "When the concentration of NGO-HA exceeds 250 μg/mL, NIR irradiation for 10 minutes can raise the temperature of the NGO-HA solution by approximately 40°C (Figure 5B), sufficient to induce a photothermal effect.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Due to the transdermal properties of HA derivatives, NGO-HA can significantly penetrate the compromised cancerous skin barrier (Figure 5C).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel C",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel C",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "However, wound healing and skin regeneration following traditional skin tumor surgery and chronic bacterial infection-induced wounds remain a challenge.157 The formation of chronic wounds is closely related to the presence of pathogenic bacteria in the postoperative skin defect.158 Timely application of antibiotics can reduce bacterial infection; however, the emergence of multidrug-resistant (MDR) bacteria increases the risk of chronic wounds.159 Wang et al156 developed a novel double-crosslinked BMH hydrogel (Figure 5D), which is injectable, adhesive, redox/photo-responsive, and has inherent antibacterial properties.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel D",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel D",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Furthermore, its antibacterial effect lasted longer, demonstrating a 100% antibacterial rate 14 days post-treatment (Figure 5E).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Additionally, the wound defects in the BMH hydrogel group almost disappeared by day 14 (Figure 5F).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel F",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel F",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "After PBVac + Light treatment, compared to the control group, the appearance of radiation dermatitis and scarring was alleviated, and hair growth was restored (Figure 5G).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel G",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel G",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Histological analysis revealed better epithelial continuity in the PBVac + Light group (Figure 5H) and increased skin appendages, including hair follicles and blood vessels, along with enhanced collagen accumulation by day 28.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel H",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel H",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "In terms of antitumor activity, PBVac showed a minimal 1.5-fold increase in tumor volume compared to a 40-fold increase in the PBS and PB nanozyme groups (Figure 5I).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel I",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel I",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Post-PTT, most cancer cells exhibited shrinkage and necrosis (Figure 6A).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Under the influence of CD47 receptor-mediated targeting by nGO-COS, the nanocomposite material achieved a high uptake intensity in melanoma cells at a relatively low concentration (5 μg/mL) (Figure 6C).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "This indicates a high photothermal conversion efficiency, which is proportional to concentration and laser power intensity, making it suitable for use as a thermotherapeutic agent (Figure 6H).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel H",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel H",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "At the same drug concentration, the number of cancer cells killed after treatment with free DTIC was significantly lower compared to nGO-COS-CD47/DTIC (Figure 6D).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The researchers constructed the nanoplatforms HA-PAMAM-COOH-TMZ and HA-PAMAM-COOH-ICG by loading temozolomide and indocyanine green onto HA-modified carboxylated polyamidoamine, respectively, for combined chemotherapy and PTT/PDT (Figure 6B).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Under near-infrared light irradiation, as the concentration of ICG increased, the temperature of HPCI rose, reaching over 50°C at its peak (Figure 6E).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel E",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel E",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Moreover, at the same concentration, the heating capacity of HPCI was similar to that of free ICG (Figure 6F), while the production of ROS was higher than that of free ICG (Figure 6G), indicating that HPCI has a good foundational capability for synergistic PTT/PDT treatment.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel F",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel G",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel F",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel G",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In the PAI validation experiments, untreated control cells showed the lowest PA amplitude, while cells incubated with MnO2 nanotubes exhibited the highest PA amplitude, which was 2.2 times higher than the control group and showed the slowest decrease in amplitude (Figure 7G).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel G",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel G",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "In PAI, the stability of nanomaterials is a non-negligible issue, in order to study the stability of MnO2 nanotubes in repetitive imaging, the researchers detected the PA signals of 2 mg/mL manganese dioxide nanotubes at 100, 2000, 4000, 8000 and 16000 laser pulses, respectively, and the results showed that there was no significant difference in the PA signals obtained at different laser pulses, and the this also proves the good stability of MnO2 nanotubes in PAI. (Figure 7A).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The experiments also ruled out the dilution effect caused by tumor growth as a factor for the reduction in PA signal, confirming the sensitivity of MnO2 nanotubes as PA probes for PAI (Figure 7B and C).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel B",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The researchers also conducted in vivo experiments and found that AuNRs could specifically accumulate at tumor sites, acting as contrast agents in PAI(Figure 7E).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel E",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel E",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Continued.Figure 8.\n\n(A) Histological staining of organs in mice 25 days after treatment.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "When PBP and BP contrast agents were separately injected intravenously into tumor-bearing mice, the mice injected with PBP exhibited higher contrast in the tumor region on PAI, with a duration of up to 24 hours (Figure 8B).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel B",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel B",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The maximum cell apoptosis rate reached 74% (Figure 8C and D).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel C",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "A noticeable infiltration of CD8+ cells in the tumor site was observed (Figure 8E–G).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel E",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Phototherapy applied to skin cancer can function through PDT, PTT, and PA (Figure 1), offering both diagnostic and therapeutic effects.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Additionally, improving platform structural compatibility to achieve multifunctional effects simultaneously, enhancing therapeutic outcomes, and increasing indications is also a viable strategy (Figure 4G).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel G",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel G",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "These effects are harnessed for targeted tumor ablation, often with minimal damage to surrounding healthy tissues (Figure 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Different tumors have varying levels of infiltration into the skin tissue, ranging from superficial in squamous cell carcinoma to deeper in melanoma (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Phototherapy is primarily categorized into PDT, PTT, and PAT, or the combined treatment of PDT and PTT,9,10 each with distinct mechanisms (Figure 1C).11 In addition, other research teams have utilized vibronic-driven action to activate aminocyanines under near-infrared light, causing membrane disruption and subsequently inducing cell death.12 Local drug application minimizes toxic side effects on normal cells, while the light-stimulated response ensures precise, targeted treatment, reducing drug waste.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In contrast, laser ablation techniques that do not include PTT drugs have already begun to have already begun to see widely clinical applications.14\n\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "These effects are harnessed for targeted tumor ablation, often with minimal damage to surrounding healthy tissues (Figure 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Different tumors have varying levels of infiltration into the skin tissue, ranging from superficial in squamous cell carcinoma to deeper in melanoma (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Phototherapy is primarily categorized into PDT, PTT, and PAT, or the combined treatment of PDT and PTT,9,10 each with distinct mechanisms (Figure 1C).11 In addition, other research teams have utilized vibronic-driven action to activate aminocyanines under near-infrared light, causing membrane disruption and subsequently inducing cell death.12 Local drug application minimizes toxic side effects on normal cells, while the light-stimulated response ensures precise, targeted treatment, reducing drug waste.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The development of skin cancer is influenced by a combination of factors, but ultraviolet (UV) radiation from sunlight is the primary pathogenic factor for the occurrence and progression of skin cancer globally.16\nMelanoma and non-melanoma skin tumors account for more than one-third of all malignant tumors, making them the most common tumor types.16 Skin cancer is classified based on the cells of origin and clinical features and can be divided into NMSC and MSC.17 NMSC includes all non-melanoma malignant tumors affecting the skin.18 In epidemiological contexts, however, NMSC specifically refers to keratinocyte carcinoma, which includes BCC, SCC, and Cutaneous T-cell lymphoma (CTCL), as these account for 99% of this group of tumors (Figure 1B).19MSC\nMelanoma is considered a multifactorial disease and has the highest mutation rate among all cancers.20 Based on the common mutation patterns in melanoma, melanoma can be categorized into four subtypes. (i) BRAF-mutant (52% present), with BRAF mutations being the largest genomic subtype of melanoma.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The development of skin cancer is influenced by a combination of factors, but ultraviolet (UV) radiation from sunlight is the primary pathogenic factor for the occurrence and progression of skin cancer globally.16\nMelanoma and non-melanoma skin tumors account for more than one-third of all malignant tumors, making them the most common tumor types.16 Skin cancer is classified based on the cells of origin and clinical features and can be divided into NMSC and MSC.17 NMSC includes all non-melanoma malignant tumors affecting the skin.18 In epidemiological contexts, however, NMSC specifically refers to keratinocyte carcinoma, which includes BCC, SCC, and Cutaneous T-cell lymphoma (CTCL), as these account for 99% of this group of tumors (Figure 1B).19.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Melanoma and non-melanoma skin tumors account for more than one-third of all malignant tumors, making them the most common tumor types.16 Skin cancer is classified based on the cells of origin and clinical features and can be divided into NMSC and MSC.17 NMSC includes all non-melanoma malignant tumors affecting the skin.18 In epidemiological contexts, however, NMSC specifically refers to keratinocyte carcinoma, which includes BCC, SCC, and Cutaneous T-cell lymphoma (CTCL), as these account for 99% of this group of tumors (Figure 1B).19.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "It was incubated with the oncolytic bacterium (Clostridium butyricum) to produce engineered oncolytic bacteria, which were then validated using a mouse model of malignant melanoma (Figure 2A).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Microscopic imaging and real-time monitoring results showed that the targeted Au@MTM-HA had the strongest ROS generation capability (Figure 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Compared to free Ce6, both PPC and PPC@HA enhanced the cellular uptake efficiency in B16 cells (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Thanks to HA-mediated targeted delivery and HA degradation-mediated charge reversal, the chemo-photodynamic combination therapy of PPC@HA+laser showed the most effective anti-tumor efficacy with the lowest tumor growth rate(Figure 2D and E).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel D",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Additionally, “hydrophobic and hydrophilic pockets” were constructed around the UCNPs, with hydrophobic PS (Ce6) and hydrophilic peroxidase (CTA) loaded into them (Figure 2G).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel G",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel G",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "After staining the cells with mitochondrial fluorescent dyes, it was observed that CTPP-modified NPs exhibited superior targeting and accumulation in the mitochondrial matrix compared to non-modified samples (Figure 2F).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel F",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel F",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Additionally, in vivo anticancer experiments revealed that tumors treated with the Ru4 + laser group significantly extended the survival time of mice (Figure 3C) and showed no significant dark toxicity (organ damage) (Figure 3E).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel E",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel E",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Although the absorption efficiency varied among different cell types, the PSs encapsulated within the cubic NPs showed enhanced cellular internalization and consequently stronger fluorescence signals (Figure 3A and B).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Surface markers on immune cells were stained 9 days after irradiation (Figure 3F).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel F",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel F",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "This leads to a higher level of infiltration of CD8 and CD4 T cells into tumors and lymph nodes (Figure 3G), which can kill tumor cells.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel G",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel G",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Ce6 generates ROS under light stimulation, which not only exerts PDT effects but also cleaves the disulfide bond to release CTX for chemotherapeutic action (Figure 3D).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel D",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel D",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "At the end of the treatment, tumor sections were stained with hematoxylin-eosin (H&E) for histological analysis, and the results showed that the synergistic treatment of psTKdC NAs and laser irradiation was effective in inducing apoptosis and necrosis of intratumor cells.(Figure 3H).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel H",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel H",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Additionally, terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling immunohistochemical staining confirmed the excellent combination of chemotherapy and photodynamic activity (Figure 3I).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel I",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel I",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "It was incubated with the oncolytic bacterium (Clostridium butyricum) to produce engineered oncolytic bacteria, which were then validated using a mouse model of malignant melanoma (Figure 2A).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Microscopic imaging and real-time monitoring results showed that the targeted Au@MTM-HA had the strongest ROS generation capability (Figure 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Compared to free Ce6, both PPC and PPC@HA enhanced the cellular uptake efficiency in B16 cells (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Thanks to HA-mediated targeted delivery and HA degradation-mediated charge reversal, the chemo-photodynamic combination therapy of PPC@HA+laser showed the most effective anti-tumor efficacy with the lowest tumor growth rate(Figure 2D and E).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel D",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Additionally, “hydrophobic and hydrophilic pockets” were constructed around the UCNPs, with hydrophobic PS (Ce6) and hydrophilic peroxidase (CTA) loaded into them (Figure 2G).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel G",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel G",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "After staining the cells with mitochondrial fluorescent dyes, it was observed that CTPP-modified NPs exhibited superior targeting and accumulation in the mitochondrial matrix compared to non-modified samples (Figure 2F).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel F",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel F",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Additionally, in vivo anticancer experiments revealed that tumors treated with the Ru4 + laser group significantly extended the survival time of mice (Figure 3C) and showed no significant dark toxicity (organ damage) (Figure 3E).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel E",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel E",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Although the absorption efficiency varied among different cell types, the PSs encapsulated within the cubic NPs showed enhanced cellular internalization and consequently stronger fluorescence signals (Figure 3A and B).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Surface markers on immune cells were stained 9 days after irradiation (Figure 3F).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel F",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel F",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "This leads to a higher level of infiltration of CD8 and CD4 T cells into tumors and lymph nodes (Figure 3G), which can kill tumor cells.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel G",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel G",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Ce6 generates ROS under light stimulation, which not only exerts PDT effects but also cleaves the disulfide bond to release CTX for chemotherapeutic action (Figure 3D).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel D",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel D",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "At the end of the treatment, tumor sections were stained with hematoxylin-eosin (H&E) for histological analysis, and the results showed that the synergistic treatment of psTKdC NAs and laser irradiation was effective in inducing apoptosis and necrosis of intratumor cells.(Figure 3H).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel H",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel H",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Additionally, terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling immunohistochemical staining confirmed the excellent combination of chemotherapy and photodynamic activity (Figure 3I).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel I",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel I",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "It was incubated with the oncolytic bacterium (Clostridium butyricum) to produce engineered oncolytic bacteria, which were then validated using a mouse model of malignant melanoma (Figure 2A).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Microscopic imaging and real-time monitoring results showed that the targeted Au@MTM-HA had the strongest ROS generation capability (Figure 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "It was incubated with the oncolytic bacterium (Clostridium butyricum) to produce engineered oncolytic bacteria, which were then validated using a mouse model of malignant melanoma (Figure 2A).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Microscopic imaging and real-time monitoring results showed that the targeted Au@MTM-HA had the strongest ROS generation capability (Figure 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Compared to free Ce6, both PPC and PPC@HA enhanced the cellular uptake efficiency in B16 cells (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Thanks to HA-mediated targeted delivery and HA degradation-mediated charge reversal, the chemo-photodynamic combination therapy of PPC@HA+laser showed the most effective anti-tumor efficacy with the lowest tumor growth rate(Figure 2D and E).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel D",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Additionally, “hydrophobic and hydrophilic pockets” were constructed around the UCNPs, with hydrophobic PS (Ce6) and hydrophilic peroxidase (CTA) loaded into them (Figure 2G).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel G",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel G",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "After staining the cells with mitochondrial fluorescent dyes, it was observed that CTPP-modified NPs exhibited superior targeting and accumulation in the mitochondrial matrix compared to non-modified samples (Figure 2F).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel F",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel F",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Compared to free Ce6, both PPC and PPC@HA enhanced the cellular uptake efficiency in B16 cells (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Thanks to HA-mediated targeted delivery and HA degradation-mediated charge reversal, the chemo-photodynamic combination therapy of PPC@HA+laser showed the most effective anti-tumor efficacy with the lowest tumor growth rate(Figure 2D and E).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel D",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Additionally, “hydrophobic and hydrophilic pockets” were constructed around the UCNPs, with hydrophobic PS (Ce6) and hydrophilic peroxidase (CTA) loaded into them (Figure 2G).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel G",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel G",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "After staining the cells with mitochondrial fluorescent dyes, it was observed that CTPP-modified NPs exhibited superior targeting and accumulation in the mitochondrial matrix compared to non-modified samples (Figure 2F).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel F",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel F",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Additionally, in vivo anticancer experiments revealed that tumors treated with the Ru4 + laser group significantly extended the survival time of mice (Figure 3C) and showed no significant dark toxicity (organ damage) (Figure 3E).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel E",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel E",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Although the absorption efficiency varied among different cell types, the PSs encapsulated within the cubic NPs showed enhanced cellular internalization and consequently stronger fluorescence signals (Figure 3A and B).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Additionally, in vivo anticancer experiments revealed that tumors treated with the Ru4 + laser group significantly extended the survival time of mice (Figure 3C) and showed no significant dark toxicity (organ damage) (Figure 3E).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel E",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel E",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Although the absorption efficiency varied among different cell types, the PSs encapsulated within the cubic NPs showed enhanced cellular internalization and consequently stronger fluorescence signals (Figure 3A and B).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Surface markers on immune cells were stained 9 days after irradiation (Figure 3F).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel F",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel F",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "This leads to a higher level of infiltration of CD8 and CD4 T cells into tumors and lymph nodes (Figure 3G), which can kill tumor cells.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel G",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel G",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Ce6 generates ROS under light stimulation, which not only exerts PDT effects but also cleaves the disulfide bond to release CTX for chemotherapeutic action (Figure 3D).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel D",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel D",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "At the end of the treatment, tumor sections were stained with hematoxylin-eosin (H&E) for histological analysis, and the results showed that the synergistic treatment of psTKdC NAs and laser irradiation was effective in inducing apoptosis and necrosis of intratumor cells.(Figure 3H).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel H",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel H",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Additionally, terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling immunohistochemical staining confirmed the excellent combination of chemotherapy and photodynamic activity (Figure 3I).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel I",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel I",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Surface markers on immune cells were stained 9 days after irradiation (Figure 3F).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel F",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel F",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "This leads to a higher level of infiltration of CD8 and CD4 T cells into tumors and lymph nodes (Figure 3G), which can kill tumor cells.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel G",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel G",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Ce6 generates ROS under light stimulation, which not only exerts PDT effects but also cleaves the disulfide bond to release CTX for chemotherapeutic action (Figure 3D).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel D",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel D",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "At the end of the treatment, tumor sections were stained with hematoxylin-eosin (H&E) for histological analysis, and the results showed that the synergistic treatment of psTKdC NAs and laser irradiation was effective in inducing apoptosis and necrosis of intratumor cells.(Figure 3H).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel H",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel H",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Additionally, terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling immunohistochemical staining confirmed the excellent combination of chemotherapy and photodynamic activity (Figure 3I).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel I",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel I",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The average inhibition rates for the NPs group, laser group, and NPs + laser group were 6%, 26%, and 57%, respectively (Figure 4A).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Melanin@RBC-M with a 1:1 weight ratio of red blood cell membrane to MCF-7 membrane proteins showed an increase in tumor temperature from 29.6°C to 54.0°C within 10 minutes (Figure 4D).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel D",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel D",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Compared to the weak tumor suppression ability of bare melanin NPs, the 1:1 group of Melanin@RBC-M demonstrated complete tumor elimination (Figure 4E and F).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel E",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The researchers conducted an in vitro evaluation of transdermal performance (Figure 4B).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The penetration efficiency of (+)T-SiDs was significantly higher than that of (+)SiDs (without TD), and the fluorescence intensity of the skin sections was also markedly stronger than the latter (Figure 4C), demonstrating higher transdermal permeability.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel C",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel C",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "However, the temperatures of the transdermally treated group increased gradually to 46°C, which was higher than that of the injected group at 43°C, and the temperatures of the injected group were higher than that of the injected group. (Figure 4D and E).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel D",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Twenty-four hours after treatment, tumor sections stained for analysis showed varying degrees of cell lysis and disruption, leading to significant necrosis and apoptosis of tumor cells (Figure 4F).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel F",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel F",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Ho et al155 developed a nanographene oxide-hyaluronic acid conjugate (NGO-HA) for photothermal ablation therapy of MSC (Figure 5A).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "When the concentration of NGO-HA exceeds 250 μg/mL, NIR irradiation for 10 minutes can raise the temperature of the NGO-HA solution by approximately 40°C (Figure 5B), sufficient to induce a photothermal effect.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Due to the transdermal properties of HA derivatives, NGO-HA can significantly penetrate the compromised cancerous skin barrier (Figure 5C).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel C",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel C",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "However, wound healing and skin regeneration following traditional skin tumor surgery and chronic bacterial infection-induced wounds remain a challenge.157 The formation of chronic wounds is closely related to the presence of pathogenic bacteria in the postoperative skin defect.158 Timely application of antibiotics can reduce bacterial infection; however, the emergence of multidrug-resistant (MDR) bacteria increases the risk of chronic wounds.159 Wang et al156 developed a novel double-crosslinked BMH hydrogel (Figure 5D), which is injectable, adhesive, redox/photo-responsive, and has inherent antibacterial properties.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel D",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel D",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Furthermore, its antibacterial effect lasted longer, demonstrating a 100% antibacterial rate 14 days post-treatment (Figure 5E).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Additionally, the wound defects in the BMH hydrogel group almost disappeared by day 14 (Figure 5F).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel F",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel F",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "After PBVac + Light treatment, compared to the control group, the appearance of radiation dermatitis and scarring was alleviated, and hair growth was restored (Figure 5G).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel G",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel G",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Histological analysis revealed better epithelial continuity in the PBVac + Light group (Figure 5H) and increased skin appendages, including hair follicles and blood vessels, along with enhanced collagen accumulation by day 28.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel H",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel H",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "In terms of antitumor activity, PBVac showed a minimal 1.5-fold increase in tumor volume compared to a 40-fold increase in the PBS and PB nanozyme groups (Figure 5I).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel I",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel I",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Post-PTT, most cancer cells exhibited shrinkage and necrosis (Figure 6A).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Under the influence of CD47 receptor-mediated targeting by nGO-COS, the nanocomposite material achieved a high uptake intensity in melanoma cells at a relatively low concentration (5 μg/mL) (Figure 6C).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "This indicates a high photothermal conversion efficiency, which is proportional to concentration and laser power intensity, making it suitable for use as a thermotherapeutic agent (Figure 6H).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel H",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel H",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "At the same drug concentration, the number of cancer cells killed after treatment with free DTIC was significantly lower compared to nGO-COS-CD47/DTIC (Figure 6D).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The researchers constructed the nanoplatforms HA-PAMAM-COOH-TMZ and HA-PAMAM-COOH-ICG by loading temozolomide and indocyanine green onto HA-modified carboxylated polyamidoamine, respectively, for combined chemotherapy and PTT/PDT (Figure 6B).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Under near-infrared light irradiation, as the concentration of ICG increased, the temperature of HPCI rose, reaching over 50°C at its peak (Figure 6E).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel E",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel E",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Moreover, at the same concentration, the heating capacity of HPCI was similar to that of free ICG (Figure 6F), while the production of ROS was higher than that of free ICG (Figure 6G), indicating that HPCI has a good foundational capability for synergistic PTT/PDT treatment.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel F",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel G",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel F",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel G",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The average inhibition rates for the NPs group, laser group, and NPs + laser group were 6%, 26%, and 57%, respectively (Figure 4A).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Melanin@RBC-M with a 1:1 weight ratio of red blood cell membrane to MCF-7 membrane proteins showed an increase in tumor temperature from 29.6°C to 54.0°C within 10 minutes (Figure 4D).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel D",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel D",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Compared to the weak tumor suppression ability of bare melanin NPs, the 1:1 group of Melanin@RBC-M demonstrated complete tumor elimination (Figure 4E and F).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel E",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The researchers conducted an in vitro evaluation of transdermal performance (Figure 4B).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The penetration efficiency of (+)T-SiDs was significantly higher than that of (+)SiDs (without TD), and the fluorescence intensity of the skin sections was also markedly stronger than the latter (Figure 4C), demonstrating higher transdermal permeability.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel C",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel C",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "However, the temperatures of the transdermally treated group increased gradually to 46°C, which was higher than that of the injected group at 43°C, and the temperatures of the injected group were higher than that of the injected group. (Figure 4D and E).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel D",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Twenty-four hours after treatment, tumor sections stained for analysis showed varying degrees of cell lysis and disruption, leading to significant necrosis and apoptosis of tumor cells (Figure 4F).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel F",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel F",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Ho et al155 developed a nanographene oxide-hyaluronic acid conjugate (NGO-HA) for photothermal ablation therapy of MSC (Figure 5A).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "When the concentration of NGO-HA exceeds 250 μg/mL, NIR irradiation for 10 minutes can raise the temperature of the NGO-HA solution by approximately 40°C (Figure 5B), sufficient to induce a photothermal effect.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Due to the transdermal properties of HA derivatives, NGO-HA can significantly penetrate the compromised cancerous skin barrier (Figure 5C).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel C",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel C",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "However, wound healing and skin regeneration following traditional skin tumor surgery and chronic bacterial infection-induced wounds remain a challenge.157 The formation of chronic wounds is closely related to the presence of pathogenic bacteria in the postoperative skin defect.158 Timely application of antibiotics can reduce bacterial infection; however, the emergence of multidrug-resistant (MDR) bacteria increases the risk of chronic wounds.159 Wang et al156 developed a novel double-crosslinked BMH hydrogel (Figure 5D), which is injectable, adhesive, redox/photo-responsive, and has inherent antibacterial properties.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel D",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel D",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Furthermore, its antibacterial effect lasted longer, demonstrating a 100% antibacterial rate 14 days post-treatment (Figure 5E).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Additionally, the wound defects in the BMH hydrogel group almost disappeared by day 14 (Figure 5F).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel F",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel F",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "After PBVac + Light treatment, compared to the control group, the appearance of radiation dermatitis and scarring was alleviated, and hair growth was restored (Figure 5G).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel G",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel G",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Histological analysis revealed better epithelial continuity in the PBVac + Light group (Figure 5H) and increased skin appendages, including hair follicles and blood vessels, along with enhanced collagen accumulation by day 28.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel H",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel H",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "In terms of antitumor activity, PBVac showed a minimal 1.5-fold increase in tumor volume compared to a 40-fold increase in the PBS and PB nanozyme groups (Figure 5I).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel I",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel I",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Post-PTT, most cancer cells exhibited shrinkage and necrosis (Figure 6A).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Under the influence of CD47 receptor-mediated targeting by nGO-COS, the nanocomposite material achieved a high uptake intensity in melanoma cells at a relatively low concentration (5 μg/mL) (Figure 6C).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "This indicates a high photothermal conversion efficiency, which is proportional to concentration and laser power intensity, making it suitable for use as a thermotherapeutic agent (Figure 6H).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel H",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel H",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "At the same drug concentration, the number of cancer cells killed after treatment with free DTIC was significantly lower compared to nGO-COS-CD47/DTIC (Figure 6D).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The researchers constructed the nanoplatforms HA-PAMAM-COOH-TMZ and HA-PAMAM-COOH-ICG by loading temozolomide and indocyanine green onto HA-modified carboxylated polyamidoamine, respectively, for combined chemotherapy and PTT/PDT (Figure 6B).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Under near-infrared light irradiation, as the concentration of ICG increased, the temperature of HPCI rose, reaching over 50°C at its peak (Figure 6E).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel E",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel E",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Moreover, at the same concentration, the heating capacity of HPCI was similar to that of free ICG (Figure 6F), while the production of ROS was higher than that of free ICG (Figure 6G), indicating that HPCI has a good foundational capability for synergistic PTT/PDT treatment.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel F",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel G",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel F",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel G",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The average inhibition rates for the NPs group, laser group, and NPs + laser group were 6%, 26%, and 57%, respectively (Figure 4A).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Melanin@RBC-M with a 1:1 weight ratio of red blood cell membrane to MCF-7 membrane proteins showed an increase in tumor temperature from 29.6°C to 54.0°C within 10 minutes (Figure 4D).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel D",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel D",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Compared to the weak tumor suppression ability of bare melanin NPs, the 1:1 group of Melanin@RBC-M demonstrated complete tumor elimination (Figure 4E and F).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel E",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The average inhibition rates for the NPs group, laser group, and NPs + laser group were 6%, 26%, and 57%, respectively (Figure 4A).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Melanin@RBC-M with a 1:1 weight ratio of red blood cell membrane to MCF-7 membrane proteins showed an increase in tumor temperature from 29.6°C to 54.0°C within 10 minutes (Figure 4D).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel D",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel D",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Compared to the weak tumor suppression ability of bare melanin NPs, the 1:1 group of Melanin@RBC-M demonstrated complete tumor elimination (Figure 4E and F).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel E",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The researchers conducted an in vitro evaluation of transdermal performance (Figure 4B).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The penetration efficiency of (+)T-SiDs was significantly higher than that of (+)SiDs (without TD), and the fluorescence intensity of the skin sections was also markedly stronger than the latter (Figure 4C), demonstrating higher transdermal permeability.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel C",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel C",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "However, the temperatures of the transdermally treated group increased gradually to 46°C, which was higher than that of the injected group at 43°C, and the temperatures of the injected group were higher than that of the injected group. (Figure 4D and E).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel D",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Twenty-four hours after treatment, tumor sections stained for analysis showed varying degrees of cell lysis and disruption, leading to significant necrosis and apoptosis of tumor cells (Figure 4F).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel F",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel F",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Ho et al155 developed a nanographene oxide-hyaluronic acid conjugate (NGO-HA) for photothermal ablation therapy of MSC (Figure 5A).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "When the concentration of NGO-HA exceeds 250 μg/mL, NIR irradiation for 10 minutes can raise the temperature of the NGO-HA solution by approximately 40°C (Figure 5B), sufficient to induce a photothermal effect.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Due to the transdermal properties of HA derivatives, NGO-HA can significantly penetrate the compromised cancerous skin barrier (Figure 5C).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel C",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel C",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "The researchers conducted an in vitro evaluation of transdermal performance (Figure 4B).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The penetration efficiency of (+)T-SiDs was significantly higher than that of (+)SiDs (without TD), and the fluorescence intensity of the skin sections was also markedly stronger than the latter (Figure 4C), demonstrating higher transdermal permeability.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel C",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel C",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "However, the temperatures of the transdermally treated group increased gradually to 46°C, which was higher than that of the injected group at 43°C, and the temperatures of the injected group were higher than that of the injected group. (Figure 4D and E).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel D",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Twenty-four hours after treatment, tumor sections stained for analysis showed varying degrees of cell lysis and disruption, leading to significant necrosis and apoptosis of tumor cells (Figure 4F).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel F",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel F",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Ho et al155 developed a nanographene oxide-hyaluronic acid conjugate (NGO-HA) for photothermal ablation therapy of MSC (Figure 5A).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "When the concentration of NGO-HA exceeds 250 μg/mL, NIR irradiation for 10 minutes can raise the temperature of the NGO-HA solution by approximately 40°C (Figure 5B), sufficient to induce a photothermal effect.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Due to the transdermal properties of HA derivatives, NGO-HA can significantly penetrate the compromised cancerous skin barrier (Figure 5C).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel C",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel C",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "However, wound healing and skin regeneration following traditional skin tumor surgery and chronic bacterial infection-induced wounds remain a challenge.157 The formation of chronic wounds is closely related to the presence of pathogenic bacteria in the postoperative skin defect.158 Timely application of antibiotics can reduce bacterial infection; however, the emergence of multidrug-resistant (MDR) bacteria increases the risk of chronic wounds.159 Wang et al156 developed a novel double-crosslinked BMH hydrogel (Figure 5D), which is injectable, adhesive, redox/photo-responsive, and has inherent antibacterial properties.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel D",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel D",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Furthermore, its antibacterial effect lasted longer, demonstrating a 100% antibacterial rate 14 days post-treatment (Figure 5E).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Additionally, the wound defects in the BMH hydrogel group almost disappeared by day 14 (Figure 5F).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel F",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel F",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "After PBVac + Light treatment, compared to the control group, the appearance of radiation dermatitis and scarring was alleviated, and hair growth was restored (Figure 5G).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel G",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel G",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Histological analysis revealed better epithelial continuity in the PBVac + Light group (Figure 5H) and increased skin appendages, including hair follicles and blood vessels, along with enhanced collagen accumulation by day 28.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel H",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel H",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "In terms of antitumor activity, PBVac showed a minimal 1.5-fold increase in tumor volume compared to a 40-fold increase in the PBS and PB nanozyme groups (Figure 5I).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel I",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel I",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Post-PTT, most cancer cells exhibited shrinkage and necrosis (Figure 6A).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "However, wound healing and skin regeneration following traditional skin tumor surgery and chronic bacterial infection-induced wounds remain a challenge.157 The formation of chronic wounds is closely related to the presence of pathogenic bacteria in the postoperative skin defect.158 Timely application of antibiotics can reduce bacterial infection; however, the emergence of multidrug-resistant (MDR) bacteria increases the risk of chronic wounds.159 Wang et al156 developed a novel double-crosslinked BMH hydrogel (Figure 5D), which is injectable, adhesive, redox/photo-responsive, and has inherent antibacterial properties.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel D",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel D",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Furthermore, its antibacterial effect lasted longer, demonstrating a 100% antibacterial rate 14 days post-treatment (Figure 5E).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Additionally, the wound defects in the BMH hydrogel group almost disappeared by day 14 (Figure 5F).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel F",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel F",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "After PBVac + Light treatment, compared to the control group, the appearance of radiation dermatitis and scarring was alleviated, and hair growth was restored (Figure 5G).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel G",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel G",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Histological analysis revealed better epithelial continuity in the PBVac + Light group (Figure 5H) and increased skin appendages, including hair follicles and blood vessels, along with enhanced collagen accumulation by day 28.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel H",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel H",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "In terms of antitumor activity, PBVac showed a minimal 1.5-fold increase in tumor volume compared to a 40-fold increase in the PBS and PB nanozyme groups (Figure 5I).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel I",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel I",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Post-PTT, most cancer cells exhibited shrinkage and necrosis (Figure 6A).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Under the influence of CD47 receptor-mediated targeting by nGO-COS, the nanocomposite material achieved a high uptake intensity in melanoma cells at a relatively low concentration (5 μg/mL) (Figure 6C).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "This indicates a high photothermal conversion efficiency, which is proportional to concentration and laser power intensity, making it suitable for use as a thermotherapeutic agent (Figure 6H).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel H",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel H",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "At the same drug concentration, the number of cancer cells killed after treatment with free DTIC was significantly lower compared to nGO-COS-CD47/DTIC (Figure 6D).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The researchers constructed the nanoplatforms HA-PAMAM-COOH-TMZ and HA-PAMAM-COOH-ICG by loading temozolomide and indocyanine green onto HA-modified carboxylated polyamidoamine, respectively, for combined chemotherapy and PTT/PDT (Figure 6B).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Under near-infrared light irradiation, as the concentration of ICG increased, the temperature of HPCI rose, reaching over 50°C at its peak (Figure 6E).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel E",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel E",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Moreover, at the same concentration, the heating capacity of HPCI was similar to that of free ICG (Figure 6F), while the production of ROS was higher than that of free ICG (Figure 6G), indicating that HPCI has a good foundational capability for synergistic PTT/PDT treatment.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel F",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel G",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel F",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel G",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Under the influence of CD47 receptor-mediated targeting by nGO-COS, the nanocomposite material achieved a high uptake intensity in melanoma cells at a relatively low concentration (5 μg/mL) (Figure 6C).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "This indicates a high photothermal conversion efficiency, which is proportional to concentration and laser power intensity, making it suitable for use as a thermotherapeutic agent (Figure 6H).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel H",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel H",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "At the same drug concentration, the number of cancer cells killed after treatment with free DTIC was significantly lower compared to nGO-COS-CD47/DTIC (Figure 6D).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The researchers constructed the nanoplatforms HA-PAMAM-COOH-TMZ and HA-PAMAM-COOH-ICG by loading temozolomide and indocyanine green onto HA-modified carboxylated polyamidoamine, respectively, for combined chemotherapy and PTT/PDT (Figure 6B).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Under near-infrared light irradiation, as the concentration of ICG increased, the temperature of HPCI rose, reaching over 50°C at its peak (Figure 6E).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel E",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel E",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Moreover, at the same concentration, the heating capacity of HPCI was similar to that of free ICG (Figure 6F), while the production of ROS was higher than that of free ICG (Figure 6G), indicating that HPCI has a good foundational capability for synergistic PTT/PDT treatment.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel F",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel G",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel F",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel G",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In the PAI validation experiments, untreated control cells showed the lowest PA amplitude, while cells incubated with MnO2 nanotubes exhibited the highest PA amplitude, which was 2.2 times higher than the control group and showed the slowest decrease in amplitude (Figure 7G).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel G",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel G",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "In PAI, the stability of nanomaterials is a non-negligible issue, in order to study the stability of MnO2 nanotubes in repetitive imaging, the researchers detected the PA signals of 2 mg/mL manganese dioxide nanotubes at 100, 2000, 4000, 8000 and 16000 laser pulses, respectively, and the results showed that there was no significant difference in the PA signals obtained at different laser pulses, and the this also proves the good stability of MnO2 nanotubes in PAI. (Figure 7A).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The experiments also ruled out the dilution effect caused by tumor growth as a factor for the reduction in PA signal, confirming the sensitivity of MnO2 nanotubes as PA probes for PAI (Figure 7B and C).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel B",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The researchers also conducted in vivo experiments and found that AuNRs could specifically accumulate at tumor sites, acting as contrast agents in PAI(Figure 7E).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel E",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel E",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Continued.Figure 8.\n\n(A) Histological staining of organs in mice 25 days after treatment.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "When PBP and BP contrast agents were separately injected intravenously into tumor-bearing mice, the mice injected with PBP exhibited higher contrast in the tumor region on PAI, with a duration of up to 24 hours (Figure 8B).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel B",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel B",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The maximum cell apoptosis rate reached 74% (Figure 8C and D).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel C",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "A noticeable infiltration of CD8+ cells in the tumor site was observed (Figure 8E–G).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel E",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "In the PAI validation experiments, untreated control cells showed the lowest PA amplitude, while cells incubated with MnO2 nanotubes exhibited the highest PA amplitude, which was 2.2 times higher than the control group and showed the slowest decrease in amplitude (Figure 7G).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel G",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel G",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "In PAI, the stability of nanomaterials is a non-negligible issue, in order to study the stability of MnO2 nanotubes in repetitive imaging, the researchers detected the PA signals of 2 mg/mL manganese dioxide nanotubes at 100, 2000, 4000, 8000 and 16000 laser pulses, respectively, and the results showed that there was no significant difference in the PA signals obtained at different laser pulses, and the this also proves the good stability of MnO2 nanotubes in PAI. (Figure 7A).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The experiments also ruled out the dilution effect caused by tumor growth as a factor for the reduction in PA signal, confirming the sensitivity of MnO2 nanotubes as PA probes for PAI (Figure 7B and C).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel B",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The researchers also conducted in vivo experiments and found that AuNRs could specifically accumulate at tumor sites, acting as contrast agents in PAI(Figure 7E).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel E",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel E",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Continued.Figure 8.\n\n(A) Histological staining of organs in mice 25 days after treatment.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "When PBP and BP contrast agents were separately injected intravenously into tumor-bearing mice, the mice injected with PBP exhibited higher contrast in the tumor region on PAI, with a duration of up to 24 hours (Figure 8B).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel B",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel B",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The maximum cell apoptosis rate reached 74% (Figure 8C and D).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel C",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "A noticeable infiltration of CD8+ cells in the tumor site was observed (Figure 8E–G).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel E",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "In the PAI validation experiments, untreated control cells showed the lowest PA amplitude, while cells incubated with MnO2 nanotubes exhibited the highest PA amplitude, which was 2.2 times higher than the control group and showed the slowest decrease in amplitude (Figure 7G).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel G",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel G",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "In PAI, the stability of nanomaterials is a non-negligible issue, in order to study the stability of MnO2 nanotubes in repetitive imaging, the researchers detected the PA signals of 2 mg/mL manganese dioxide nanotubes at 100, 2000, 4000, 8000 and 16000 laser pulses, respectively, and the results showed that there was no significant difference in the PA signals obtained at different laser pulses, and the this also proves the good stability of MnO2 nanotubes in PAI. (Figure 7A).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The experiments also ruled out the dilution effect caused by tumor growth as a factor for the reduction in PA signal, confirming the sensitivity of MnO2 nanotubes as PA probes for PAI (Figure 7B and C).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel B",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "In the PAI validation experiments, untreated control cells showed the lowest PA amplitude, while cells incubated with MnO2 nanotubes exhibited the highest PA amplitude, which was 2.2 times higher than the control group and showed the slowest decrease in amplitude (Figure 7G).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel G",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel G",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "In PAI, the stability of nanomaterials is a non-negligible issue, in order to study the stability of MnO2 nanotubes in repetitive imaging, the researchers detected the PA signals of 2 mg/mL manganese dioxide nanotubes at 100, 2000, 4000, 8000 and 16000 laser pulses, respectively, and the results showed that there was no significant difference in the PA signals obtained at different laser pulses, and the this also proves the good stability of MnO2 nanotubes in PAI. (Figure 7A).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The experiments also ruled out the dilution effect caused by tumor growth as a factor for the reduction in PA signal, confirming the sensitivity of MnO2 nanotubes as PA probes for PAI (Figure 7B and C).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel B",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The researchers also conducted in vivo experiments and found that AuNRs could specifically accumulate at tumor sites, acting as contrast agents in PAI(Figure 7E).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel E",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel E",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Continued.Figure 8.\n\n(A) Histological staining of organs in mice 25 days after treatment.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The researchers also conducted in vivo experiments and found that AuNRs could specifically accumulate at tumor sites, acting as contrast agents in PAI(Figure 7E).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel E",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel E",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "When PBP and BP contrast agents were separately injected intravenously into tumor-bearing mice, the mice injected with PBP exhibited higher contrast in the tumor region on PAI, with a duration of up to 24 hours (Figure 8B).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel B",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel B",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The maximum cell apoptosis rate reached 74% (Figure 8C and D).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel C",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "A noticeable infiltration of CD8+ cells in the tumor site was observed (Figure 8E–G).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel E",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "When PBP and BP contrast agents were separately injected intravenously into tumor-bearing mice, the mice injected with PBP exhibited higher contrast in the tumor region on PAI, with a duration of up to 24 hours (Figure 8B).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel B",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel B",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The maximum cell apoptosis rate reached 74% (Figure 8C and D).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel C",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "A noticeable infiltration of CD8+ cells in the tumor site was observed (Figure 8E–G).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel E",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Phototherapy applied to skin cancer can function through PDT, PTT, and PA (Figure 1), offering both diagnostic and therapeutic effects.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Additionally, improving platform structural compatibility to achieve multifunctional effects simultaneously, enhancing therapeutic outcomes, and increasing indications is also a viable strategy (Figure 4G).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel G",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel G",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Phototherapy applied to skin cancer can function through PDT, PTT, and PA (Figure 1), offering both diagnostic and therapeutic effects.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Additionally, improving platform structural compatibility to achieve multifunctional effects simultaneously, enhancing therapeutic outcomes, and increasing indications is also a viable strategy (Figure 4G).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel G",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel G",
        "figure_key": "figure_4"
      }
    ]
  }
]